<SEC-DOCUMENT>0001193125-22-262585.txt : 20221014
<SEC-HEADER>0001193125-22-262585.hdr.sgml : 20221014
<ACCEPTANCE-DATETIME>20221014070553
ACCESSION NUMBER:		0001193125-22-262585
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20221014
FILED AS OF DATE:		20221014
DATE AS OF CHANGE:		20221014

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KAZIA THERAPEUTICS LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		221310257

	BUSINESS ADDRESS:	
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		THREE INTERNATIONAL TOWERS LEVEL 24,
		STREET 2:		300 BARANGAROO AVENUE
		CITY:			SYDNEY NSW
		STATE:			C3
		ZIP:			2000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NOVOGEN LTD
		DATE OF NAME CHANGE:	19981228
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d402146d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN PRIVATE ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-16</FONT> OR
<FONT STYLE="white-space:nowrap">15d-16</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of October, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number <FONT STYLE="white-space:nowrap">000-29962</FONT> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Kazia Therapeutics Limited </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Three
International Towers Level&nbsp;24 300 Barangaroo Avenue Sydney NSW 2000 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form <FONT STYLE="white-space:nowrap">20-F</FONT> or Form <FONT
STYLE="white-space:nowrap">40-F.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
20-F&nbsp;&nbsp;&#9745;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form <FONT STYLE="white-space:nowrap">40-F&nbsp;&nbsp;&#9744;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form <FONT
STYLE="white-space:nowrap">6-K</FONT> in paper as permitted by Regulation <FONT STYLE="white-space:nowrap">S-T</FONT> Rule 101(b)(7):&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION CONTAINED IN THIS FORM <FONT STYLE="white-space:nowrap">6-K</FONT> REPORT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;14, 2022, Kazia Therapeutics Limited filed with the ASX the 2022 Notice of Annual General Meeting, Explanatory
Statement and Proxy Form, a copy of which is attached hereto as Exhibit&nbsp;99.1 and is incorporated herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT
LIST </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="93%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d402146dex991.htm">2022 Notice of Annual General Meeting, Explanatory Statement and Proxy Form of Kazia Therapeutics Limited dated October&nbsp;14, 2022 </A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kazia Therapeutics Limited</B> (Registrant) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="25%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Karen Krumeich</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Karen Krumeich </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Chief Financial Officer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Date: October&nbsp;14, 2022 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d402146dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>KAZIA THERAPEUTICS LIMITED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ABN 37 063 259 754 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>THE MATTERS RAISED IN THIS DOCUMENT WILL AFFECT YOUR SHAREHOLDING IN THE COMPANY. YOU ARE ADVISED TO READ THIS DOCUMENT IN ITS ENTIRETY
BEFORE THE ANNUAL GENERAL MEETING REFERRED TO BELOW IS CONVENED. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>IF YOU ARE IN ANY DOUBT ABOUT THE ACTION YOU SHOULD TAKE IN
RESPONSE TO THIS DOCUMENT, PLEASE CONSULT YOUR STOCKBROKER, SOLICITOR, ACCOUNTANT OR OTHER PROFESSIONAL ADVISER. </I></B></P> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g402146g04q07.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>2022 NOTICE OF ANNUAL GENERAL MEETING, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY STATEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>PROXY FORM
</B></P> <P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">THIS IS A NOTICE OF THE 2022 ANNUAL GENERAL MEETING OF THE COMPANY TO BE HELD AS A HYBRID MEETING AT <B>10.00 AM (SYDNEY TIME) ON
WEDNESDAY 16</B><B></B><B>&nbsp;NOVEMBER 2022 AT LEVEL 46, TOWER ONE - INTERNATIONAL TOWERS SYDNEY, 100 BARANGAROO AVENUE, SYDNEY NSW AND VIA LIVE WEBCAST AT https://meetnow.global/MLNFM5D</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A PROXY FORM FOR USE AT THIS
MEETING IS INCLUDED WITH THIS DOCUMENT. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TO BE VALID, PROXY FORMS MUST BE COMPLETED AND RETURNED TO THE COMPANY&#146;S SHARE REGISTRY,
COMPUTERSHARE, BY<B> NO LATER THAN 10.00 AM (SYDNEY TIME) ON 14</B><B></B><B>&nbsp;NOVEMBER 2022.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14&nbsp;October 2022 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Shareholder </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are pleased to invite you to attend the
2022 Annual General Meeting of the shareholders of Kazia Therapeutics Limited (<B>Kazia </B>or <B>Company</B>), which is scheduled to be held as a hybrid meeting at 10.00am (Sydney time) on Wednesday 16&nbsp;November 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Enclosed with this letter is the Notice of Meeting, which details the items of business to be dealt with at the Meeting. We hope you will consider the matters
presented to you in this Notice and support us in our endeavours to continue to grow the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The full range of R&amp;D activities of the Company is
presented on the Kazia website which can be found at (www.kaziatherapeutics.com). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>AGENDA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Resolutions on the agenda for this Meeting are for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adoption of Remuneration Report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Re-Election</FONT> of Steven Coffey; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The grant of up to 3,500,000 Options to Dr James Garner; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The ratification of prior issue of ATM Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of Additional Placement capacity under Listing Rule 7.1A; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adoption of New Constitution; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of Proportional Takeover Provisions. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HYBRID MEETING </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In line with changing trends, the Board
have decided to hold a hybrid meeting this year, with a physical presence and also the ability for shareholders to attend virtually. Shareholders dialling in will do so via a URL which is set out on the front page of this Notice of Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whether you plan to attend the Meeting in person, virtually, or are not able to attend at all, the Board encourages you to lodge your votes online at
www.investorvote.com.au. You will require the control number (found on the Notice and Access Form), your HIN/SRN and postcode/domicile code to access online voting. This will allow the proceedings at the meeting to flow smoothly and allow the
maximum amount of time to discuss the Company&#146;s operations and progress. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Yours faithfully </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g402146sp5.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Kate Hill </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Company Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">On behalf of the Board of Directors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF GENERAL MEETING </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Kazia Therapeutics Limited </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ABN 37 063 259 754 </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Time and Place of
Meeting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTICE </B>is hereby given that the 2022 Annual General Meeting of Kazia Therapeutics Limited ABN&nbsp;37 063&nbsp;259&nbsp;754
(<B>Company</B>) will be held at the following time and location, and at that Meeting the business specified below will be conducted. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Date:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">16&nbsp;November 2022</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Time</B>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10.00am (Sydney time)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Attend in person at:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Level&nbsp;46, Tower One - International Towers Sydney, 100 Barangaroo Avenue, Sydney NSW</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Attend&nbsp;virtually&nbsp;via</B>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>https://meetnow.global/MLNFM5D</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ordinary Business </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FINANCIAL STATEMENTS AND REPORTS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To receive and consider
the financial statements of the Group for the 12 months ended 30&nbsp;June 2022 and the related reports of the Directors and the Auditor (as contained in the Annual Report). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTION 1 &#150; ADOPTION OF REMUNERATION REPORT </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To
consider and, if thought fit, to pass the following resolution as a <FONT STYLE="white-space:nowrap">non-binding</FONT><B> Ordinary Resolution</B>: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Resolution 1 &#150; Adoption of Remuneration Report </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report for the year
ended 30&nbsp;June 2022 as set out in the Annual Report for the year ended 30&nbsp;June 2022 be adopted on the terms and conditions set out in the Explanatory Statement.&#148; </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please note that section 250R(3) of the Corporations Act provides that the vote on this Resolution is advisory only and does not bind the Directors or the
Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTION 2 &#150; <FONT STYLE="white-space:nowrap">RE-ELECTION</FONT> OF STEVEN COFFEY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To consider and, if thought fit, to pass the following resolution as an<B> Ordinary Resolution</B>: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Resolution 2 &#150; Re-Election of Steven Coffey </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;That, for the purposes of Listing Rule 14.4 and clauses 21.1 and 21.7 of the Constitution, Steven Coffey, who retires by rotation and
being eligible, is <FONT STYLE="white-space:nowrap">re-elected</FONT> as a Director.&#148; </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTION 3 &#150; APPROVAL OF GRANT OF OPTIONS TO DR JAMES GARNER </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To consider and, if thought fit, to pass the following resolution as an<B> Ordinary Resolution</B>: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Resolution 3 &#150; Approval of grant of Options to Dr James Garner </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;That, for the purposes of Listing Rule 10.14 and for all other purposes, approval is given to the grant of 3,500,000 Options and issue
of 3,500,000 Shares on exercise of those Options, to Dr James Garner, the Managing Director of the Company, under the Plan and otherwise on the terms and conditions set out in the Explanatory Statement.&#148; </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTION 4 &#150; RATIFICATION OF PRIOR ISSUE OF ATM SHARES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To consider and, if thought fit, to pass the following resolution as an<B> Ordinary Resolution</B>: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Resolution 4 &#150; Ratification of prior issue of Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the prior allotment and issue of 17,160,230
ATM Shares on the terms and conditions set out in the Explanatory Statement.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTION 5 &#150; APPROVAL OF ADDITIONAL PLACEMENT CAPACITY
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To consider and, if thought fit, to pass the following resolution as a<B> Special Resolution</B>: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Resolution 5 &#150; Approval of additional placement capacity under Listing Rule 7.1A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;That, for the purposes of Listing Rule 7.1A and for all other purposes, Shareholders approve the additional capacity of the Company to
issue Equity Securities up to 10% of the issued capital of the Company (at the time of the issue) calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and on the terms and conditions set out in the Explanatory Statement.&#148;
</I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTION 6 &#150; ADOPTION OF NEW CONSTITUTION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To consider and, if thought fit, to pass the following resolution as a<B> Special Resolution</B>: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Resolution 6 &#150; Adoption of New Constitution </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;That, for the purposes of sections 136 of the Corporations Act and for all other purposes, the current constitution of the Company be
repealed and the new constitution in the form as signed by the Chair for identification purposes (excluding clause 14) be adopted as the constitution of the Company.&#148; </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTION 7 &#150; APPROVAL OF PROPORTIONAL TAKEOVER PROVISIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To consider and, if thought fit, to pass the following resolution as a<B> Special Resolution</B>: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Resolution 7&#150; Approval of Proportional Takeover Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>&#147;That, for the purposes of sections 136 and 648G of the Corporations Act and for all other purposes, the proportional takeover
provisions contained in Schedule 2 to the Explanatory Memorandum be inserted, as clause 14, into the new constitution approved under Resolution 6.&#148; </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Exclusion Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Resolution 3: Approval of Grant of Options to Dr Garner</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will disregard any votes cast in favour of Resolution 3 by or on behalf of a person referred to in Listing Rules 10.14.1, 10.14.2
or 10.14.3 who is eligible to participate in the Plan or an Associate of those persons.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, this does not apply to a vote cast in favour of the Resolution by:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;a person as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(c)&#8194;&#8201;&#8202;a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf
of a beneficiary provided the following conditions are met:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not an Associate of a person excluded from voting, on the Resolution; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Resolution 4: Ratification of Prior Issue of ATM Shares</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will disregard any votes cast in favour of Resolution 4 by or on behalf of a person who participated in the issue or an Associate
of those persons.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, this does not apply to a vote cast in favour of the
Resolution by:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;a
person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;the Chair as proxy or
attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(c)&#8194;&#8201;&#8202;a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf
of a beneficiary provided the following conditions are met:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not an Associate of a person excluded from voting, on the Resolution; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Resolution 5: Approval of Additional Placement Capacity under Listing Rule 7.1A</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will disregard any votes cast in favour of Resolution 5 by or on behalf of any person who is expected to participate in, or who
will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of Shares) or an Associate of those persons.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, this does not apply to a vote cast in favour of the Resolution by:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;a person as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(c)&#8194;&#8201;&#8202;a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf
of a beneficiary provided the following conditions are met:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(i)&#8195;the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from
voting, and is not<I> </I>an Associate of a person excluded from voting, on the Resolution; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(ii)&#8194;&#8201;the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Company confirms that as at the date of dispatch of
this Notice, the Company is not proposing to make an issue of Equity Securities under Listing Rule 7.1A.2 and therefore, no existing Shareholders&#146; votes will be excluded under the above voting exclusion statement. However, in the event that
between the date of the Notice and the date of the Meeting, the Company proposes to make an issue of Equity Securities under Listing Rule 7.1A.2 to one or more existing Shareholders, those Shareholders&#146; votes will be excluded under the above
voting exclusion statement.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Voting prohibition</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Resolutions 1 and 3</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A vote on Resolutions 1 and 3 must not be cast:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;by or on behalf of a member of Key Management Personnel (in the case of Resolution 1, details
of whose remuneration are included in the Remuneration Report for the year ended 30&nbsp;June 2022) or a Closely Related Party of such member (regardless of the capacity in which the vote is cast); or</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;by a person appointed as
a proxy, where that person is either a member of Key Management Personnel or a Closely Related Party of such a member,</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">unless the vote is cast as a proxy for a person permitted to vote on Resolutions 1 or 3:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(c)&#8194;&#8201;&#8202;in accordance with a
direction as to how to vote on the proxy form; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(d)&#8194;&#8201;&#8202;by the Chair to an express authorisation to exercise the proxy even though it is connected
with the remuneration of a member of Key Management Personnel.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">If you are a member
of Key Management Personnel or a Closely Related Party of a member of Key Management Personnel (or acting on behalf of them) and purport to cast a vote that will be disregarded by the Company, you may be liable for an offence for breach of voting
restrictions that apply to you under the Corporations Act.</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>By order of the Board </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g402146sp5.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kate Hill </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company Secretary
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: 14&nbsp;October 2022 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These notes and the following Explanatory Statement form part of the Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are unable to attend the Meeting in person or via the live webcast, but wish to appoint a proxy, please complete and return a copy of the proxy form
attached to the Notice by no later than 10.00am (Sydney time) on 14&nbsp;November 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Determination of entitlement to attend and vote </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has determined under regulation 7.11.37 of the <I>Corporations Regulations 2001</I> (Cth) that for the purpose of voting at the Annual General
Meeting or adjourned meeting, securities are taken to be held by those persons recorded in the Company&#146;s register of Shareholders as at 7:00pm (Sydney time) on 14&nbsp;November 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proxies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Shareholder who is entitled to attend, in
person or virtually, and cast a vote at the Annual General Meeting is entitled to appoint a proxy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proxy need not be a Shareholder. A Shareholder who
is entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If no proportions or numbers are specified, each proxy may exercise half of the Shareholder&#146;s
votes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you wish to appoint a proxy and are entitled to do so, then complete the attached proxy form in accordance with the instructions on the form
and return the completed proxy form to the Share Registry in a manner indicated on the form no later than 10.00am (Sydney time) on 14&nbsp;November 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Chair is appointed, or taken to be appointed, as a proxy but the appointment does not direct the proxy how to vote on a Resolution, then the Chair
intends to exercise the relevant Shareholder&#146;s votes in favour of the relevant Resolution (subject to the other provisions of these notes, including any voting exclusions set out in the Notice). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Attorneys </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Shareholder may appoint an attorney to vote
on his or her behalf. For an appointment to be effective for the Meeting, the instrument affecting the appointment (or a certified copy of it) must be received by the Company or the Share Registry by no later than 10.00am (Sydney time) on
14&nbsp;November 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate representatives </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
corporation may elect to appoint a representative, rather than a proxy, under the Corporations Act, in which case the Company will require written proof of the representative&#146;s appointment which must be lodged with or presented to the Company
before the Annual General Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Voting on
Resolutions set out in the Notice will be conducted by poll. Upon a poll, every Shareholder who is present in person or by proxy, representative or attorney will have one vote for each Share held by that Shareholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EXPLANATORY STATEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Explanatory Statement is included in and forms part of the Notice of Meeting. It contains an explanation of, and information about, the Resolutions to be
considered at the Meeting. It is given to Shareholders to help them determine how to vote on the Resolutions set out in the Notice of Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders should read this Explanatory Statement in full and, if in doubt about what to do in relation to a Resolution, Shareholders should consult their
stockbroker, solicitor or financial or other professional advisor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ordinary Business </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Financial Statements and Reports </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Corporations
Act requires the Company to lay before the Annual General Meeting the Financial Report, Directors&#146; Report (including the Remuneration Report) and the Auditor&#146;s Report for the financial year ended 30&nbsp;June 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shareholders will be offered the opportunity to discuss the Financial Report, Directors&#146; Report and Auditor&#146;s Report at the Meeting. Copies of these
reports can be found on the Company&#146;s website http://www.kaziatherapeutics.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no requirement for Shareholders to approve the Financial
Report, Directors&#146; Report and Auditor&#146;s Report. Shareholders will be offered the following opportunities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">discuss the Annual Report for the financial year ended 30&nbsp;June 2022; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ask questions or make comments on the management of the Company; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ask the Auditor questions about the conduct of the audit and preparation and content of the Auditor&#146;s
Report. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to taking questions at the Annual General Meeting, written questions to the Chair about the management of the
Company, or to the Auditor about: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the preparation and content of the Auditor&#146;s Report; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the conduct of the audit; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">accounting policies adopted by the Company in relation to the preparation of the financial statements; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the independence of the Auditor in relation to the conduct of the audit, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">may be submitted no later than 5 business days before the Annual General Meeting to the Company Secretary at the Company&#146;s registered office or by email
to info@kaziatherapeutics.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>RESOLUTIONS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(A)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Resolution 1 &#150; Adoption of Remuneration Report</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board comment </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board offers the following
observations on the Remuneration Report: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Board and its Remuneration and Nomination Committee take a balanced view between the need to pay market rates
to attract talent, and the financial resources of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In particular, as in prior years, the Board and the Remuneration and Nomination Committee have focussed the
remuneration spend on personnel best placed to advance the clinical stage assets of the Company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As set out in the Notice of Meeting,
any member of Key Management Personnel, together with a Closely Related Party of those members, are excluded from casting a vote on Resolution 1. Accordingly, the Board abstains from making a recommendation in relation to Resolution 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chair intends to exercise all undirected proxies in favour of Resolution 1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Chair is appointed as your proxy and you have not specified the way the Chair is to vote on Resolution 1, by signing and returning the Proxy Form, you
are considered to have provided the Chair with an express authorisation for the Chair to vote the proxy in accordance with the Chair&#146;s intention, even though the Resolution is connected directly or indirectly with the remuneration of Key
Management Personnel. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background to the Resolution </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Remuneration Report is contained in the &#147;Directors&#146; Report&#148; section of the Annual Report, a copy of which can be found on the Company&#146;s
website, http://www.kaziatherapeutics.com. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Publicly listed companies are required to submit their remuneration reports to a vote for adoption at each of
their annual general meetings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whilst the Resolution is to be determined as an ordinary resolution, it is advisory only and does not bind the Directors
or the Company. However, if more than 25% of the votes cast on Resolution 1 are voted against the adoption of the Remuneration Report, the Remuneration Report for the following year must either address any comments received from Shareholders or
explain why no action has been taken in response to those comments. If, at the following annual general meeting of the Company, the Remuneration Report is again voted against by 25% or more of votes cast, a &#145;spill resolution&#146; will be put
to Shareholders. If at least 50% of the votes cast are in favour of the &#145;spill resolution&#146;, a special meeting of the Company will be held within 90 days at which the Directors (other than the Managing Director) in office at the time of the
second annual general meeting of the Company must resign and stand for <FONT STYLE="white-space:nowrap">re-election.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the Company&#146;s 2021
Annual General Meeting for the 2021 Remuneration Report, the votes cast against this Resolution were less than 25%, therefore the current &#147;strike&#148; count is zero. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During this item of business, Shareholders will have the opportunity to ask questions about and comment on the Remuneration Report. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(B)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Resolution 2 &#150; <FONT STYLE="white-space:nowrap">Re-Election</FONT> of Steven Coffey</U>
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background to the Resolution </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clause 21.1 of the Constitution provides that, amongst other things, a Director must not hold office without
<FONT STYLE="white-space:nowrap">re-election</FONT> for more than 3 years or following the third annual general meeting after that Director last appointment or <FONT STYLE="white-space:nowrap">re-election,</FONT> whichever is the longer. This
mirrors the requirements of Listing Rule 14.4. Clause 21.7 provides that a Director who retires from office under the Constitution will be eligible for <FONT STYLE="white-space:nowrap">re-election</FONT> to the Board at the meeting at which that
Director retires from office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The length of time a Director has been in office is computed from that Director&#146;s last election. Mr Coffey was last <FONT
STYLE="white-space:nowrap">re-elected</FONT> to the Board at the 2019 Annual General Meeting of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at the date of this Notice of Meeting,
the Board comprised of three Directors who are subject to rotation. The Director longest in office without being <FONT STYLE="white-space:nowrap">re-elected</FONT> is Steven Coffey and is therefore required to retire. Being eligible, Mr Coffey
offers himself to be <FONT STYLE="white-space:nowrap">re-elected</FONT> as a Director. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Steven Coffey credentials </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven is a Chartered Accountant and registered company auditor and has over 35 years experience in the accounting and finance industry. He has been a partner
with the chartered accounting firm Watkins Coffey Martin which recently merged with Charternet Chartered Accountants and Steven is a consultant to that group. Steven sits on the board of a number of large private family companies and audits a number
of large private companies and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> entities. He has previously been a director of The Docyard Limited (ASX:TDY). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board Recommendation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors (Mr Coffey
abstaining) recommend that you vote in favour of Resolution 2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chair intends to exercise all undirected proxies in favour of Resolution 2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(C)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Resolution 3 &#150; Approval of grant of Options to Dr James Garner</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASX Listing Rule 10.14 states that a listed company must not permit a director, as well as other specified individuals, to acquire securities under an employee
incentive scheme without the approval of ordinary shareholders given by ordinary resolution. Dr James Garner, the Chief Executive Officer and Managing Director of the Company, is a director of the Company and so covered by ASX Listing Rule 10.14.1.
The purpose of Resolution 3 is to seek approval from Shareholders under Listing Rule 10.14 and for all other purposes for the Board to grant 3,500,000 Options, to Dr James Garner under the Plan, which was approved by Shareholders at the 2021 Annual
General Meeting of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background to the Resolutions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The broad remuneration policy of the Company is to ensure that the remuneration package of key management personnel reflects their duties and responsibilities
and is competitive in attracting, retaining and motivating people of the highest quality. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">non-executive</FONT>
Directors, being all of the Directors other than Dr Garner, believe that the grant of the Options the subject of Resolution 3 to Dr Garner is an appropriate way to set long term incentive as part of Dr Garner&#146;s remuneration package, encouraging
a continuous high level of service in future, and aligning his incentive to the improvement of shareholder value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors believe that Dr Garner
has added enormous value to the Company during FY22 to position it to deliver future value, and hence would like to recognise this with an equity grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In respect of the 3,500,000 Options that will be issued to Dr Garner in relation to his performance in FY22, the options will vest in six equal portions on a <FONT
STYLE="white-space:nowrap">6-monthly</FONT> basis, with the first tranche vesting on or around 17&nbsp;May 2023. The Options will have a <FONT STYLE="white-space:nowrap">4-year</FONT> life. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Resolution 3 is approved, the Company will issue the Options to Dr Garner in accordance with this Explanatory Statement. If Resolution 3 is not approved,
the Company will not be able to issue the Options and so the Company will need to look to incentivise Dr Garner in other ways. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please see the summary of
the terms and conditions of the Options below for more details. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Chapter 2E of the Corporations Act </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chapter 2E of the Corporations Act provides that a public company must not, without the approval of the company&#146;s members, give a financial benefit to a
related party, unless it falls within a specified exception in the Corporations Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr Garner is a related party of the Company for the purposes of
section 228(2) of the Corporations Act as he is a Director. Therefore, the grant of Options the subject of Resolution 3 will constitute the giving of a financial benefit to a related party for the purposes of section 229(3)(e) of the Corporations
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;211 of the Corporations Act provides an exemption to the restrictions in Chapter 2E of the Corporations Act on the giving of financial
benefits to related parties, if the financial benefit is remuneration to an officer or employee of a public company and the remuneration is reasonable given the circumstances of the public company and the officer or employee (including the
responsibilities involved in the office or employment). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is the view of the Board (excluding Dr Garner) that the terms of the financial benefit, being
the grant of Options the subject of Resolution 3, in conjunction with other components of Dr Garner&#146;s remuneration, comprises reasonable remuneration having regard to the Company&#146;s and Dr Garner&#146;s circumstances (including his
responsibilities as Chief Executive Officer and Managing Director), and would therefore fall within an exemption set out in section 211 of the Corporations Act. The Options the subject of Resolution 3 will (if approved) be granted to Dr Garner for
the sole purpose of remunerating him for his services as the Chief Executive Officer and Managing Director of the Company in relation to FY22. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Terms and Conditions of the Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Option will be issued to Dr James Garner on the following terms and conditions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Amount payable for each Option</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Options will be granted for nil consideration.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Exercise Price</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Exercise Price for the Options will be set at a premium of 43% to the 5 day VWAP on the issue date, and is expected to be approximately $0.26 per Option.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Quotation of Shares issued on exercise</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Upon exercise of any of the Options, the Company will apply for quotation of the Shares issued as a result of the exercise, subject to any restrictions imposed by the ASX.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Vesting Dates and Vesting Conditions</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Options will vest and be exercisable as follows:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">1)&#8195;&#8202;583,333 Options to vest on 17&nbsp;May 2023;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">2)&#8195;&#8202;583,333 Options to vest on
17&nbsp;November 2023;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">3)&#8195;&#8202;583,334 Options to vest on 17&nbsp;May 2024;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">4)&#8195;&#8202;583,333 Options to vest on
17&nbsp;November 2024;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">5)&#8195;&#8202;583,333 Options to vest on 17&nbsp;May 2025; and</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">6)&#8195;&#8202;583,334 Options to vest on
17&nbsp;November 2025.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Options will vest in accordance with the terms of the
Plan.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Option Period</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Once vested, Options may be exercised at any time up to 5.00pm (Sydney time) on 17&nbsp;November 2026. Options which are not exercised during the Option Period will automatically lapse and be cancelled.</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Specific information required by Listing Rule 10.15 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to and in accordance with Listing Rule 10.15, the following information is provided: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Options will be granted to Dr James Garner, Chief Executive Officer and Managing Director;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr James Garner falls within the category of Listing Rule 10.14.1 as he is a Director; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a total of 3,500,000 Options will be granted to Dr Garner, with a total of up to 3,500,000 Shares to be issued
if all these Options are exercised; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr James Garner&#146;s remuneration arrangements for FY22 is as follows: </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Base Salary</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$600,015 per annum (inclusive of superannuation).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Performance Bonus</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Each year Dr Garner may receive a performance bonus valued at up to 50% of his base salary (given at the discretion of the Board and measured against the key performance indicators in place for the relevant year).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Other Incentives</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1,200,000 Options were issued in November 2019, of which all are now vested</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">800,000 Options were issued in November 2020, of which 400,000 are now vested</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2,500,000 Options were issued in November 2021, of which 500,000 are now
vested</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the following securities have been previously issued to Dr James Garner under the Plan: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as approved by Shareholders at the Company&#146;s 2020 Annual General Meeting, 800,000 Options have been issued
at no cost to Dr James Garner during 2020 under the Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as approved by Shareholders at the Company&#146;s 2021 Annual General Meeting, 2,500,000 Options have been
issued at no cost to Dr James Garner during 2021 under the Plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Options will have an exercise price of approximately $0.26 per Option, vest in six equal tranches at <FONT
STYLE="white-space:nowrap">6-monthly</FONT> intervals following their date of issue and expire on 17&nbsp;November 2026.a summary of the other material terms of the Options is set out above; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the use of Options is to align Director remuneration with the creation of Shareholder value as the Options to
be granted to Dr Garner (and therefore the potential issuance of Shares) is linked to the performance of the Company. In addition, in order for the Company to attract and retain quality Directors, the issuance of Options forms part of a desirable
remuneration package; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company values each Option at $0.09 as determined by a Black-Scholes valuation having regard to the
underlying Share price, risk free interest rate and volatility of the underlying Share price. As a result, the Company ascribes a total value of A$315,000 to the Options to be issued; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the allotment and issue of the Options will occur as soon as practicable after the Meeting, but in any event no
later than three years after the Meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Options will be issued for nil consideration; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a summary of the material terms of the Plan is set out in Schedule 1; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(l)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">there is no loan in relation to the proposed issue of Options to Dr Garner; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(m)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">details of any securities issued under the Plan will be published in the Company&#146;s annual report relating
to the period in which they were issued, along with a statement that approval for the issue was obtained under Listing Rule 10.14; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(n)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any additional persons covered by Listing Rule 10.14 who become entitled to participate in an issue of
securities under the Plan after the Resolutions are approved and who were not named in the Notice will not participate until approval is obtained under that rule; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(o)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a voting exclusion statement is included in the Notice for Resolution 3. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board recommendation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors (other than Dr Garner) do not have an interest in the outcome of Resolution 3 and recommend that Shareholders vote in favour of Resolution 3 for
the following reasons: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Options are considered by the Directors to provide a cost-effective means of giving an incentive to Dr
Garner to advance the Company&#146;s interests in accordance with the directions given from time to time by the Board; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the number of Options to be issued is considered to be in line with the number issued to directors of similar
companies. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr Garner, who stands to gain personally from the grant of the Options, declines to make any recommendation in relation to
Shareholders&#146; consideration of the Resolution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note:</B> Shareholders&#146; approval for the Resolution is being sought pursuant to Listing Rule
10.14 for the grant of the Options. Consequently, in accordance with Listing Rule 7.2 (Exception 14), Shareholder approval under Listing Rule 7.1 is not required for the grant of these Options. In addition, in accordance with Listing Rule 7.2
(Exception 9), Shareholder approval under Listing Rule 7.1 will not be required for the issue of any Shares issued pursuant to the exercise of those Options. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(D)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Resolution 4 &#150; Ratification of prior issue of ATM Shares</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background to the Resolution </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Between 24&nbsp;May
2022 and 7&nbsp;October 2022, the Company issued 17,160,230 Shares (<B>ATM Shares</B>) under its <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">At-The-Market</FONT></FONT> (<B>ATM</B>) financing facility, announced by the Company
on 23&nbsp;April 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the ATM facility, the Company may offer and sell via Oppenheimer up to US$35&nbsp;million of its Shares, in the form of
American Depository Shares (<B>ADSs</B>), with each ADS representing 10 Shares. Sales of ADSs under the ATM may be made from time to time, with the timing and amount of any sales to be determined by Kazia at its sole discretion, based on a variety
of factors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares under the facility are issued at market price and attract low levels of banking fees, accordingly providing an attractive form of
financing for the Company with minimal dilution to existing shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table shows details of the ATM Share issues: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Date&nbsp;of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>issue<U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No&nbsp;of&nbsp;shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issue&nbsp;price</B><br><B>($USD)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issue&nbsp;price</B><br><B>($AUD</B><br><B>equivalent)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B><br><B>raised&nbsp;($AUD)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issued&nbsp;under</B><br><B>LR&nbsp;7.1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issued&nbsp;under</B><br><B>LR&nbsp;7.1A</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">24-May-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,256</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">2-Jun-22</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,025</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">6-Jun-22</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,710</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.603</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">74,258</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,710</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">9-Jun-22</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">603,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.603</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">507,036</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">603,500</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">14-Jun-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,940</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,583</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,940</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">15-Jun-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.831</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,661</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">20-Jun-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,072,660</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.869</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,540,403</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,072,660</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">7-Jul-22</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">573,370</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">407,201</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">573,370</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">8-Aug-22</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,561,490</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,839,346</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,561,490</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">9-Aug-22</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.190</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,723</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">10-Aug-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">158,020</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,949</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">158,020</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">11-Aug-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">330,960</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.171</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,868</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">330,960</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-Aug-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,247,440</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">308,050</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,247,440</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">12-Sep-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">651,030</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">143,964</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">651,030</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">13-Sep-22</FONT></FONT></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,350</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,350</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">7-Oct-22</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">736,760</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">131,797</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">736,760</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Totals</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,160,230</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,160,320</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,160,230</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Resolution 4 seeks Shareholder ratification pursuant to Listing Rule 7.4 for the prior issue and allotment of the ATM Shares
issued under Listing Rule 7.1 and Listing Rule 7.1A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Listing Rule 7.1 provides that, subject to certain exceptions, the Company must not, without the
approval of Shareholders, issue or agree to issue more Equity Securities during any <FONT STYLE="white-space:nowrap">12-month</FONT> period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the
commencement of that <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Listing Rule 7.1A, an eligible entity can seek approval from its
members, by way of a special resolution passed at its annual general meeting, to increase this 15% limit by an extra 10% to 25%. At the 2021 Annual General Meeting of the Company, the Company sought and obtained approval of Shareholder under Listing
Rule 7.1A to increase its 15% placement capacity to 25%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issue of Shares pursuant to the ATM facility did not fall within any of the specified
exceptions set out in Listing Rule 7.2 and as it has not yet been approved by Shareholders, it effectively reduced the Company&#146;s capacity to issue further Equity Securities without shareholder approval under Listing Rules 7.1 and 7.1A for the <FONT
STYLE="white-space:nowrap">12-month</FONT> period following the issue date of the ATM Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Listing Rule 7.4 provides that if the Company in general
meeting ratifies the previous issue of Equity Securities made pursuant to Listing Rules 7.1 or 7.1A (and provided the previous issue did not breach Listing Rules 7.1 or 7.1A) those Equity Securities will be deemed to have been made with Shareholder
approval for the purposes of Listing Rule 7.1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By ratifying the issue of the ATM Shares, the subject of Resolution 4, the Company will retain maximum
flexibility to issue Equity Securities in the future up to the 15% annual placement capacity set out in Listing Rule 7.1 (and if Resolution 5 is approved, up to the 25% expanded limit under Listing Rule 7.1A) without the requirement to obtain prior
Shareholder approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Resolution 4 is not approved, the ATM Shares will be included in the Company&#146;s 15% Placement Capacity, effectively
decreasing the number of Equity Securities it can issue without Shareholder approval until one year after the issue of Shares, unless an exemption applies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Resolution 4 is an ordinary resolution. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Specific
information required by Listing Rule 7.5 </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to and in accordance with Listing Rule 7.5, the following information is provided: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the ATM Shares were sold on market by Oppenheimer and the Company to market participants, who, as far as the
Company is aware, are not related parties or associates of any related parties of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a total of 17,160,230 ATM Shares were issued, of which 17,160,230 were issued under Listing Rule 7.1 and none
were issued under Listing Rule 7.1A; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the ATM Shares were issued as fully paid ordinary shares and rank equally in all respects with the
Company&#146;s existing Shares on issue; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the ATM Shares were issued on the dates show in the above table; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issue price of the ATM Shares is shown in US dollars in the above table as well as equivalent value in
Australian dollars, converted at the daily spot rate on the date of issue; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the funds raised from the issue of the Shares are being used (i)&nbsp;to progress the Company&#146;s clinical
trials, and (ii)&nbsp;for working capital; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a voting exclusion statement is included in the Notice for Resolution 4. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board recommendation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors recommend that
you vote in favour of this Resolution 4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chair intends to exercise all undirected proxies in favour of Resolution 4. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(E)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Resolution 5 &#150; Approval of Additional Placement Capacity</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background to the Resolution </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Resolution 5 seeks
Shareholder approval to permit the Company to issue an additional 10% of its issued capital over a <FONT STYLE="white-space:nowrap">12-month</FONT> period in accordance with Listing Rule 7.1A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Listing Rule 7.1, the Company may issue Equity Securities equal to up to 15% of its issued ordinary securities in any
<FONT STYLE="white-space:nowrap">12-month</FONT> period without seeking Shareholder approval. In addition, under Listing Rule 7.1A, eligible entities may seek shareholder approval to issue further Equity Securities up to 10% of the issued ordinary
securities of the entity within the 12 months from approval being granted, in addition to the 15% capacity under Listing Rule 7.1 (<B>Additional Placement Capacity</B>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An entity is eligible to seek Additional Placement Capacity if it is not included in the S&amp;P/ASX300 index and has a market capitalisation of
$300&nbsp;million or less. As the Company satisfies these requirements as at the date of this Notice, it is eligible to seek Shareholder approval for the Additional Placement Capacity. For illustrative purposes, the Company&#146;s market
capitalisation was approximately $28&nbsp;million based on a closing price of $0.185 per Share on 27&nbsp;September 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company desires to maintain
flexibility to respond promptly to maximise opportunities afforded by capital markets, and to do this the Company again seeks approval from Shareholders for the Additional Placement Capacity. The most likely use of this increased capacity would be
to take advantage of an opportunity to raise additional funds to apply to the progression of our lead candidates, paxalisib and EVT801, through clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Resolution 5 is passed, the effect will be that the Company will be able to issue Equity Securities under the Additional Placement Capacity in addition to
the Company&#146;s 15% annual placement capacity under Listing Rule 7.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Resolution 5 is not passed, the effect will be that the Company will not be
able to issue any Equity Securities under the Additional Placement Capacity and will have to rely upon its 15% annual placement capacity under Listing Rule 7.1 of the issue of Equity Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Resolution 5 is a special resolution. Accordingly, at least 75% of the votes cast by Shareholders present and entitled to vote must be cast in favour of the
Resolution for it to be passed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors believe that Resolution 5 is in the best interests of the Company and unanimously recommend that
Shareholders vote in favour of this Resolution 5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chair intends to exercise all undirected proxies in favour of Resolution 5. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of Listing Rule 7.1A </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of Equity
Securities that may be issued (if this Resolution 5 is passed) will be determined in accordance with the following formula as prescribed in Listing Rule 7.1A.2: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional Placement Capacity =<B> (A x D) &#150; E</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">where:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>A</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is the number of fully paid ordinary securities on issue 12 months before the date of issue or agreement to
issue: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">plus the number of fully paid ordinary securities issued in the 12 months under an exception in Listing Rule
7.2 other than exception 9, 16 or 17; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">plus the number of fully paid ordinary securities issued in the 12 months on the conversion of convertible
securities within Listing rule 7.2 exception 9 where (i)&nbsp;the convertible securities were issued or agreed to be issued before the commencement of the relevant period or (ii)&nbsp;the issue of, or agreement to issue, the convertible securities
was approved or taken under the Listing rules to have been approved, under Listing Rules 7.1 or 7.4; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">plus the number of partly paid ordinary securities that became fully paid in the 12 months under Listing Rule
7.2 exception 16 where (i)&nbsp;the agreement was entered into before the commencement of the 12 month period or (ii)&nbsp;the agreement or issue was approved, or taken under the Listing Rules to have been approved, under Listing Rules 7.1 or 7.4;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">plus the number of any other fully paid ordinary securities issued in the 12 months with approval under Listing
Rule 7.1 or 7.4; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">plus the number of partly paid ordinary securities that become fully paid in the 12 months,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">less the number of fully paid ordinary securities cancelled in the 12 months. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>D</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is 10% </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>E</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>is the number of Equity Securities issued or agreed to be issued under Listing Rule 7.1A.2 in the 12
months where the issue or agreement has not been subsequently approved by holders of ordinary securities under Listing Rule 7.4. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Specific information required by Listing Rule 7.3A </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to and in accordance with Listing Rule 7.3A, information is provided in relation to the approval of the Additional Placement Capacity as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Period for which the Additional Placement Capacity will be valid</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Resolution 5 is passed, the Additional Placement Capacity will be valid during the period from the date of the Meeting and will expire on
the earlier of:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;the
date that is 12 months after the date of the Meeting;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;the time and date of the Company&#146;s next annual general meeting; and</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(c)&#8194;&#8201;&#8202;the time and date on
which the Company receives approval by Shareholders for a transaction under Listing Rules 11.1.2 (a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking),</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>(Approval Period).</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Minimum price at which the Equity Securities may be issued</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Equity Securities to be issued will be in existing class of quoted securities and will be issued for cash consideration at an issue price
per Equity Security of not less than 75% of the VWAP for the Equity Securities calculated over the 15 trading days on which trades in that class were recorded immediately before:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;the date on which the
price, at which the securities are to be issued, is agreed by the Company and the recipient of the Equity Securities; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;if the securities are not issued within 10 trading days of that date, the date on which the
securities are issued.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Purposes for which the Equity Securities may be issued</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While there are not current intentions to issue any Equity Securities under the Additional Placement Capacity, the Company intends that any
funds raised from the issue of any Equity Securities under the Additional Placement Capacity (if approved) will likely be applied for advancing the Company&#146;s key assets, paxalisib and EVT801, through clinical trials.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The specific purposes for which any particular issue is made under the Additional
Placement Capacity will be disclosed by way of an ASX announcement at the time of the issue. The Company will comply with the disclosure obligations under Listing Rules 7.1A.4 and 3.10.5A upon issue of any Equity Securities under the Additional
Placement Capacity.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Risk of economic and voting dilution</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An issue of Equity Securities under Listing Rule 7.1A involves the risk of economic and voting dilution for existing Shareholders. The risks
include:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;the market
price for the Equity Securities may be significantly lower on the issue date than on the date of the approval under Listing Rule 7.1A; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;the Equity Securities may be issued at a price that is at a discount to the market price for
the Equity Securities on the issue date.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In accordance with Listing Rule 7.3A.2, a
table describing the notional possible dilution, based upon various assumptions as stated, is set out below.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Details of the Company&#146;s allocation policy for issues under approval</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s allocation policy is dependent on the prevailing market conditions at the time of any proposed issue under the Additional
Placement Capacity. The identity of the allottees of Equity Securities under the Additional Placement Capacity will be determined on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis having regard
to the factors including, but not limited to, the following:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;the methods of raising funds that are available to the Company, including but not limited to,
issues in which existing security holders can participate;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;the effect of the issue of Equity Securities on the control of the Company;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(c)&#8194;&#8201;&#8202;the financial situation
and solvency of the Company; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(d)&#8194;&#8201;&#8202;advice from corporate, financial and broking advisers (if applicable).</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The allottees under the Additional Placement Capacity have not been determined as at the
date of this Notice but may include existing Shareholders and/or new Shareholders who are not related parties or associates of a related party of the Company.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Further, if the Company is successful in acquiring new intellectual property assets or investments, it is possible that the allottees under the Additional
Placement Capacity will be the vendors of the new intellectual property assets or investments.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Previous approvals under Listing Rule 7.1A</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Approval was sought and obtained for the purposes of Listing Rule 7.1A at the 2021 Annual General Meeting. No Equity Securities were issued under Listing Rule 7.1A in the 12 months preceding the date of the Meeting.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below shows the dilution of existing Shareholders on the basis of the current market price of
Shares and the current number of Shares for variable &#147;A&#148; calculated under the formula set out in Listing Rule 7.1A.2 as at the date of this Notice of Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table shows two examples where variable &#147;A&#148; has increased, by 50% and 100%. Variable &#147;A&#148; is based on the number of Shares the Company
has on issue as at the date of the Notice of Meeting. The number of Shares on issue may increase as a result of issues of Shares that do not require Shareholder approval (for example, a pro rata entitlement issue or scrip issued under a takeover
offer) or as a result of future specific placements under Listing Rule 7.1 that are approved at future Shareholder meetings </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table also shows two
examples where the issue price of Shares has decreased by 50% and increased by 100% as against the current market price of the Company&#146;s Shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Dilution</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Variable</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD ROWSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>50% decrease</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Issue Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>100% increase</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$0.09</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$0.19</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$0.37</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current variable A</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">151,112,796</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Shares issued (10%<BR>voting dilution)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,111,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,111,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,111,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Funds raised</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,397,793.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,795,586.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,591,173.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;A&#148; is a 50% increase to</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">226,669,194</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Shares issued (10%<BR>voting dilution)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,666,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,666,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,666,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Funds raised</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,096,690.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,193,380.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,386,760.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#147;A&#148; is a 100% increase to</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">302,225,592</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Shares issued (10%<BR>voting dilution)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,222,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,222,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,222,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Funds raised</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,795,586.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,591,173.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,182,346.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Note</B>: Current Variable A refers to the calculation required by Listing Rule 7.1A.2 which, in the
Company&#146;s case, equates to the current number of Shares on issue. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table above has been prepared on the following assumptions:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Resolution 5 is passed by Shareholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company issues the maximum number of Shares available under the Additional Placement Capacity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">no convertible securities convert into Shares before the date of the issue of the Shares available under the
Additional Placement Capacity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the 10% voting dilution reflects the aggregate percentage dilution against the issued Share capital at the time
of issue (which is why the voting dilution is shown in each example as 10%); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the table does not show an example of dilution that may be caused to a particular Shareholder by reason of a
Share issue under the Additional Placement Capacity, based on that Shareholder&#146;s holding at the date of the Annual General Meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the table shows only the effect of issues of Equity Securities under the Additional Placement Capacity, not
under the Company&#146;s 15% annual placement capacity under Listing Rule 7.1; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company has not issued any Equity Securities in the 12 months prior to the Meeting that were not issued
under an exception in Listing Rule 7.2, with approval under Listing Rule 7.1 or ratified under Listing Rule 7.4; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issue of Equity Securities under the Additional Placement Capacity consists only of Shares; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the issue price is $0.185 per Share, being the closing price of Shares on ASX on Tuesday, 27&nbsp;September
2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(F)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Resolutions 6 and 7 &#150; Adoption of New Constitution and Approval of Proportional Takeover
Provisions</U> </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background to the Resolutions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has recently undertaken a review of the Constitution and proposes a number of modifications to reflect certain changes to the Corporations Act,
Listing Rules and corporate governance practices to achieve efficient and flexible administration of the Company and relations with Shareholders, and to facilitate virtual general meetings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, pursuant to section 648G(4) of the Corporations Act, the Company wishes to seek Shareholder approval to insert the proportional takeover
provisions contained in Schedule 2, as clause 14 in the new constitution approved under Resolution 6. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adoption of a new constitution </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Resolution 6 seeks approval of shareholders to adopt a new constitution of the Company. Rather than amend the Constitution, the Company proposes to adopt a new
constitution reflecting these amendments (but otherwise in the current form). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A complete copy of the proposed new Constitution will be tabled at the
Meeting and signed by the Chair for identification, Copies can also be obtained from the Company Secretary before the meeting free of charge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following is an overview of the proposed key amendments to the current Constitution: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Virtual meetings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A number of amendments are proposed to be made to the Constitution to facilitate the holding of virtual general meetings by the Company following recent
changes to the Corporations Act permitting companies to hold hybrid and virtual meetings. The amendments include clarifying that Directors may determine that a meeting be held by means of virtual meeting technology or other communication facilities
that gives the members as a whole a reasonable opportunity to participate and vote, and providing the Chair with additional powers to adjourn a meeting in particular circumstances (eg due to technical difficulties). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Electronic dispatch of meeting materials </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance
with recent changes to the Corporations Act, the constitution has been amended to include a new clause which permits the Company to electronically dispatch the notice of general meeting and instrument of proxy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted securities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Constitution has been amended
to comply with the requirements of Listing Rule 15.12, which sets out certain provisions that a constitution of a listed company must have in respect of restricted securities. The amendments clarify that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a holder of restricted securities must not dispose of, or agree or offer to dispose of, the restricted
securities during the escrow period for those restricted securities, except as permitted by the Listing Rules or the ASX; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the restricted securities are in the same class as quoted securities of the Company, the holder will be
taken to have agreed in writing that the restricted securities are to be kept on the Company&#146;s issuer sponsored <FONT STYLE="white-space:nowrap">sub-register</FONT> and are to have a holding lock applied for the duration of the escrow period
for those restricted securities; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company must refuse to acknowledge a disposal (including, without limitation, registering a transfer) of
restricted securities during the escrow period for any restricted securities except as permitted by the Listing Rules or the ASX; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a holder of restricted securities will not be entitled to participate in any return of capital on those
restricted securities during the escrow period for those restricted securities except as permitted by the Listing Rules or the ASX; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if a holder of restricted securities breaches a restriction deed or a provision of the Constitution restricting
a disposal of those restricted securities, the holder will not be entitled to any dividend or distribution, or to exercise any voting rights, in respect of the restricted securities for so long as the breach continues. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Joint holders </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In anticipation for the CHESS replacement
expected in April 2023, the Constitution has been amended to increase the number of joint holders permitted in the register of members from three joint holders to four joint holders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Reasonable fee for <FONT STYLE="white-space:nowrap">off-market</FONT> share transfers </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Constitution has been amended to permit the Company to charge a reasonable fee to register paper-based Share transfers, subject to compliance with the
Listing Rules. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Approval of proportional takeover provisions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Resolution 7 seeks Shareholder approval to insert the proportional takeover provisions contained in Schedule 2, as clause 14 in the new constitution approved
under Resolution 6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A proportional takeover bid is a takeover bid where the offer made to each Shareholder is only for a proportion of the
Shareholder&#146;s Shares. If a Shareholder accepts, in full, an offer under a proportional takeover bid, the Shareholder will only dispose of a specified portion of their Shares in the Company and retain the balance of the Shares. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Effect of the proportional takeover provisions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
proportional takeover provisions in the Constitution provide that where offers have been made under a proportional takeover bid in respect of a class of securities in the Company, the registration of a transfer giving effect to a contract resulting
from the acceptance of an offer made under such a proportional takeover bid is prohibited unless and until a resolution to approve the proportional takeover bid is passed by Shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In particular: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if a proportional takeover bid is made for securities of the Company, the Directors must ensure that a meeting
of Shareholders is convened to vote on a resolution to approve that bid; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the bidder and persons associated with the bidder may not vote; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">approval of the bid will require a simple majority of the votes cast; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the meeting must take place more than 14 days before the last day of the bid period (<B>Approving Resolution
Deadline</B>); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if the resolution is rejected before the Approving Resolution Deadline, the bid cannot proceed and any
transfers giving effect to takeover contracts for the bid will not be registered; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the bid will be taken to have been approved if, as at the end of the day before the Resolution Deadline, the
resolution has not been voted on. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proportional takeover provisions do not apply to full takeover bids. If the proportional takeover
provisions are renewed, they will cease to apply at the end of three years after renewal unless renewed by a special resolution of Shareholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Reasons for proposing Resolution 7 </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the absence of the
proportional takeover provisions, a proportional takeover bid may result in control of the Company changing without Shareholders having an opportunity to dispose of all their Shares. By making a partial bid, a bidder can obtain practical control of
the Company by acquiring less than a majority interest. Shareholders could be exposed to the risks of passing control to the bidder without payment of an adequate control premium for all their Shares and being left with a minority interest in the
Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Presently proposed acquisitions </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As at the
date of this Notice of Meeting, no Director is aware of any proposal to acquire, or to increase the extent of, a substantial interest in the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Advantages and disadvantages during the period in which they have been in effect </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors consider that the proportional takeover provisions had no advantages or disadvantages for them during the period in which they have been in
effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The advantages and disadvantages of the proportional takeover provisions for Shareholders include those set out below, which were applicable
during the period in which they have been in effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Potential advantages and disadvantages </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The potential advantages of the proportional takeover provisions for Shareholders include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">providing the right to discuss, in a meeting called specifically for that purpose, and then decide, by majority
vote, whether an offer under a proportional takeover bid should proceed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">potentially not allowing control of the Company to pass without payment of a control premium;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">assisting the prevention of Shareholders being locked in as a minority; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">increasing the bargaining power of Shareholders which may assist in ensuring that any proportional takeover bid
is adequately priced; and/or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">potentially increasing the likelihood of a full takeover bid rather than a proportional takeover bid.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The potential disadvantages of the proportional takeover provisions for Shareholders include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">imposing a hurdle to, and potentially discouraging the making of, provisional takeover bids;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">potentially reducing the likelihood of success of a proportional takeover bid; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">possible reduction or loss of opportunities for Shareholders sell some or all of their Shares at a premium;
and/or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">potentially causing some Shareholders to form the view that the proportional takeover provisions impose an
unreasonable restriction on their ability to freely deal with their Shares. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Corporations Act, an amendment to the Company&#146;s Constitution (which includes a renewal
of the proportional takeover provisions) can only be effected by way of a Special Resolution passed by its Shareholders. Therefore, Resolutions 6 and 7 are Special Resolutions that can only be passed if at least 75% of the total votes cast by
Shareholders entitled to vote on Resolutions 6 and 7 are voted in its favour. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board recommendation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors recommend that you vote in favour of Resolutions 6 and 7. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chair intends to exercise all undirected proxies in favour of Resolutions 6 and 7. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GLOSSARY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this Document, the following terms have the meanings prescribed below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Australian dollars.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Annual Report</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Company&#146;s annual report for the <FONT STYLE="white-space:nowrap">12-month</FONT> period ended 30&nbsp;June 2022.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Associate</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Has the meaning given to that term in sections 10 to 17 of the Corporations Act.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>ASX</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ASX Limited ACN 008 624 691 or the securities exchange market operated by it, as the context requires.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Auditor</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Grant Thornton Audit Pty Limited ACN 130 913 594.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Auditor&#146;s Report</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Means the Auditor&#146;s report on the Financial Report.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Board</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The board of Directors.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Chair</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The person chairing the Meeting.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Closely Related Party</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Has the meaning given to that term in section 9 of the Corporations Act.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Company or Kazia</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Kazia Therapeutics Limited ACN 063 259 754.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Constitution</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The constitution of the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Corporations Act</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>Corporations Act 2001</I> (Cth).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Director</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A director of the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Directors&#146; Report</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Means the annual directors&#146; report prepared under Chapter 2M of the Corporations Act for the Company and its controlled entities.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Equity Security</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Has the meaning given to that term in Listing Rule 19.12.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Explanatory Statement</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The explanatory statement accompanying the Notice of Meeting.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Financial Report</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Means the annual financial report prepared under Chapter 2M of the Corporations Act for the Company and its controlled entities.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>FY</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Means the financial year of 12 months ending 30 June.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Group</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Company and is related bodies corporate (as that term is defined in the Corporations Act).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Key Management Personnel</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The key management personnel whose remuneration details are included in the Remuneration Report.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Listing Rules</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The listing rules of the ASX as amended from time to time.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Meeting or Annual General Meeting</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Annual General Meeting of the Company convened by the Notice.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Notice or Notice of Meeting</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The notice convening this Meeting of which the Explanatory Statement forms part.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Option</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">An option to acquire a Share.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Ordinary Resolution</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A resolution of Shareholders that is approved by Shareholders who are entitled to vote on that resolution and who hold more than 50% (in number) of all voting Equity Securities of the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Plan</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The employee incentive scheme titled &#147;Kazia Therapeutics Limited Employee Share Option Plan&#148;.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Proxy Form</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The proxy form attached to this Notice.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Remuneration Report</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The remuneration report set out in the Annual Report.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Resolution</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A resolution set out in the Notice.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Securities</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Collectively, any Shares or other securities issued by the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Share</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A fully paid ordinary share in the issued capital of the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Share Registry</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Computershare Investor Services Pty Limited.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Shareholder</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A registered holder of one or more Share(s).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Trading Day</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Has the meaning given to that term in Listing Rule 19.12.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>USD</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">US dollars.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VWAP</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">In respect of a quoted class of Equity Securities, the volume weighted average price of that class of Equity Securities sold on the ASX during the prescribed number of trading days immediately preceding and including the date on
which such price is to be determined, but does not include any transactions defined in the ASX Operating Rules as &#147;special&#148; crossings prior to the commencement of normal trading, crossings during the after hours adjust phase nor any
overseas trades or trades pursuant to the exercise of options over ordinary shares in the capital of the Company.</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of key terms of Kazia Therapeutics Limited Employee Share Option Plan </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Description</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Eligibility</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offers may be made at the Board&#146;s discretion to any employee, long term contractor (full time or part time), officer or director of the Company or an Associated Company, or any other person so designated by the Board (or
committee of the Board).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Options</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#147;Options&#148; are an entitlement to receive fully paid ordinary shares upon satisfaction of applicable conditions and payment of an applicable exercise price.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Invitations under the Plan</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Plan, the Board may make offers or invitations at its discretion, subject to any requirement for shareholder approval.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Board has the discretion to set the terms and conditions on which it will invite an
employee to apply for or accept a grant of Options in individual offer documents including as to the number of Options and the exercise conditions.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Exercise Price</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When the Board (or committee of the Board) decides to invite an employee to apply for or receive an Option, it must, in its absolute
discretion (but subject to adjustment under the terms of the Plan), also determine the exercise price for that Option subject to any restrictions in the Listing Rules.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The exercise price may be a dollar amount or an amount determined in the future under a formula.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Exercise</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subject to the satisfaction of any applicable exercise condition, the terms of the invitation and the Company&#146;s share trading policy, a participant may exercise any Option granted to the participant (that is capable of
exercise) on a day which is after the vesting period and before the end of the Option Period.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Vesting and lapsing</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vesting of the Awards is to be specified in the individual invitation and is to be, in respect of an Option, the period of two years after
the date of grant or another period determined by the Board (either generally or in a particular case).</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#147;Option Period&#148; for each Option is (subject to any terms or condition in the Plan or the invitation that has the effect of lapsing an Option),
the period starting on the date on which the Company grants the Option and ending, unless another period is specified in the invitation made in relation to that Option:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;on the fifth anniversary of that date; or</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;at the end of any other
period permitted by law that the Board may from time to time determine.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Option
lapses:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(a)&#8194;&#8201;&#8202;on exercise
of the Option;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(b)&#8194;&#8201;&#8202;if the
Option is not exercised during the Option Period, at the end of the Option Period;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(c)&#8194;&#8201;&#8202;if the Participant (i)&nbsp;dies, (ii) ceases to be an employee during the Vesting Period or
(iii)&nbsp;in a clawback scenario; or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">(d)&#8194;&#8201;&#8202;if the Company commences to be wound
up.</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Description</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Cessation of employment</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a participant ceases to be an employee after the vesting period and before the end of the Option Period, the Board may in its absolute
discretion (on any conditions which it thinks fit) decide that the Option does not lapse but lapses at the time and subject to the conditions it may specify by notice to the participant.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In making that decision, the Board may consider any relevant matter (including, without
limitation, whether the participant ceased to be an employee by reason of retirement, <FONT STYLE="white-space:nowrap">ill-health,</FONT> accident or redundancy).</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Clawback and preventing inappropriate benefits</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Plan provides the Board with broad clawback powers if the Board considers the participant&#146;s conduct, capability or performance justifies the variation.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Change in control</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon a change of control the participant&#146;s unvested Options will immediately vest in full.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Change in Control occurs:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">a)&#8195;&#8201;where, as a result of any
takeover bid, scheme of arrangement or any other event or transaction, a person or entity becomes entitled to more than 50% of the Shares or to all or substantially all of the Group&#146;s business and assets (provided that no sale or transfer
undertaken in respect of an internal reorganisation of the structure, business or assets of the Group shall constitute a Change of Control Event); or</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">b)&#8195;&#8202;any other event determined by the Board to constitute a &#147;Change of Control Event&#148; for the
purposes of these Rules (excluding, for the avoidance of doubt, an internal reorganisation of the structure, business or assets of the Group).</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Reconstructions, corporate action, rights issues, bonus issues etc.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Plan includes specific provisions dealing with rights issues, bonus issues, and corporate actions and other capital reconstructions.
These provisions are intended to ensure that there is no material advantage or disadvantage to the participant in respect of their Options as a result of such corporate actions.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Participants are not entitled to participate in new pro rata issues of shares by the
Company prior to the vesting (and exercise if applicable) of their Options.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Where
during the Option Period the Company makes a <FONT STYLE="white-space:nowrap">pro-rata</FONT> bonus issue to holders of Shares and an Option is not exercised before the record date to determine entitlements to that bonus issue, the number of
securities to be allocated on exercise of the Option is the number of Shares before that bonus issue plus the number of securities which would have been allocated to the holder if the Option had been exercised before that record date.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP><B>Post vesting conditions</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subject to any disposal restrictions the Board may at any time determine, no disposal restrictions will apply on Shares acquired by participants on vesting other than Company&#146;s share trading
policy.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="73%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Description</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Other terms</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Plan contains customary and usual terms for dealing with administration, variation, suspension and termination of the Plan.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Board or a committee appointed by the Board for the purpose under the constitution
of the Company may manage and administer the Plan for the Company and the committee has all powers necessary to do so.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>US addendum</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to provide Options to US based employees, a schedule has been added to the Plan to govern offers of Options to US taxpayers. Key
terms include:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Options
may be incentive stock options (<B>ISOs</B>) or <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options (<B>NQSOs</B>);</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Exercise price may not be less than the fair market value of a Share on the grant date;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;a maximum of 13,000,000
Shares may be issued pursuant to the exercise of ISOs; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;maximum period for ISOs is 10 years.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proportional Takeover Provisions </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>&#147;14.</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I>Proportional takeover bids </I></B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Definitions </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.1</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>In this clause 14:</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B><I>Approving resolution</I></B> <I>has the same meaning as in section 648D of the Act;</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B><I>Approving resolution deadline</I></B> <I>has the same meaning as in section 648D of the Act;</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B><I>Associate</I></B> <I>has the meaning specified in section 9 of the Act for the purposes of Chapter 6 of the Act; and</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><B><I>Proportional takeover bid</I></B> <I>has the meaning specified in section 9 of the Act.</I> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Prohibition on registration of transfer unless takeover scheme approved </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.2</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Where an offer has been made under a proportional takeover bid in respect of Shares included in a class of
Shares in the Company, registration of a transfer to effect a contract resulting from the acceptance of an offer made under the proportional takeover bid is prohibited unless and until a resolution to approve the proportional takeover bid is passed
in accordance with this clause 14 and this Constitution</I>. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Approving resolution </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.3</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>An approving resolution under this clause 14 is to be voted on at a meeting, convened and conducted by the
Company, of the persons entitled to vote on that resolution under the Act</I>. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Entitlement to vote on approving resolution
</I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.4</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>A person (other than the bidder or an associate of the bidder) who, as at the end of the day on which the
first offer under the proportional takeover bid was made, held Shares included in that class is entitled to vote on an approving resolution and, for the purposes of so voting, is entitled to one vote for each of those Shares</I>.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Bidder and associates not entitled to vote </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.5</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I></I></B><I>The bidder or an associate of the bidder is not entitled to vote on an approving resolution
under this clause 14.</I> </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Approving resolution passed </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><I></I><B><I>14.6</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I></I></B><I>An approving resolution under this clause 14 is taken to have been passed if the proportion
which the number of votes in favour of the resolution bears to the total number of votes on the resolution is greater than 50%, and otherwise is taken to have been rejected.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General meeting provisions to apply </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.7</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I></I></B><I>The provisions of this Constitution which apply to a general meeting of the Company apply,
with any modifications as the circumstances require, to a meeting convened under this clause 14 and apply as if that meeting were a general meeting of the Company.</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Meeting to be held before approving resolution deadline </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.8</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I></I></B><I>Where takeover offers have been made under a proportional takeover bid, the Directors of the
Company must ensure that a resolution to approve the proportional takeover bid is voted on in accordance with this clause 14 before the approving resolution deadline in relation to the proportional takeover bid</I>. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice as to whether approving resolution is passed </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.9</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I></I></B><I>Where a resolution to approve a proportional takeover bid is voted on in accordance with this
clause 14, before the approving resolution deadline in relation to the proportional takeover bid, the Company must, on or before the approving resolution deadline:</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>give to the bidder; and</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><I>(2)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>serve on the Home Branch,</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:10pt; font-family:Times New Roman"><I>a written notice stating that a resolution to approve the proportional takeover bid has been voted on and that the resolution has been
passed, or has been rejected, as the case may be.</I> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Approving resolution deemed to have been passed </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I></I></B><I>14.10</I><B><I></I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Where, as at the end of the day before the approving resolution deadline in relation to a proportional
takeover bid under which offers have been made, no resolution to approve the proportional takeover bid has been voted on in accordance with this clause 14, a resolution to approve the proportional takeover bid is, for the purposes of this clause 14,
deemed to have been passed in accordance with this clause 14.</I> </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Effect of this clause </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B><I>14.11</I></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><I></I></B><I>This clause 14 ceases to have effect on the third anniversary of the later of the date of its
adoption and its most recent renewal.&#148;</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g402146g02g02.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Annual General Meeting of Shareholders of Annual General Meeting of Shareholders of Kazia Therapeutics Limited Kazia Therapeutics
Limited Date: November 16, 2022 to be held November 16, 2022 See Voting Instruction On Reverse Side. For Holders as of October 7, 2022 Please make your marks like this: x Use pen only Recommend Directors For Against Abstain AGENDA . MAIL The
Resolutions on the agenda for this Meeting are for: 1. Adoption of Remuneration Report; provided &#149; Mark, sign and date your Voting Instruction Form. 2. Re-Election of Steven Coffey; &#149; Detach your Voting Instruction Form. &#149; Return your
Voting Instruction Form in the postage-paid 3. The grant of up to 3,500,000 Options to Dr James Garner; 4. The rati?cation of prior issue of ATM Shares; envelope envelope provided. 5. Approval of Additional Placement capacity under Listing Rule
7.1A; the 6. Adoption of New Constitution; andin 7. Approval of Proportional Takeover Provisions. portion All votes must be received by 12:00 PM New York City time on November 8, 2022. this just PROXY TABULATOR FOR return KAZIA THERAPEUTICS LIMITED
and P.O. BOX 8016 perforation CARY, NC 27512-9903 the at carefully separate Please EVENT # CLIENT # Authorized Signatures - This section must be completed for your instructions to be executed. _____________________________________
__________________________ Please Sign Here Please Date Above _____________________________________ __________________________ Please Sign Here Please Date Above Copyright &copy; 2022 Mediant Communications Inc. All Rights Reserved </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.25in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g402146g03g03.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Kazia Therapeutics Limited Instructions to The Bank of New York Mellon, as Depositary (Must be received prior to 12:00 PM New York City
time on November 8, 2022) The undersigned registered holder of American Depositary Receipts (&#147;Receipts&#148;) of Kazia Therapeutics Limited (the &#147;Company&#148;) hereby requests and instructs The Bank of New York Mellon, as Depositary, to
endeavor, insofar as practicable, to vote or cause to be voted the amount of shares or other Deposited Securities represented by such Receipt(s) registered in the name of the undersigned on the books of the Depositary as of the close of business
October 7, 2022 at the Annual General Meeting of the Shareholders of Kazia Therapeutics Limited to be held on November 16, 2022, in respect of the resolutions specified on the reverse. NOTE: 1. Please direct the Depositary how it is to vote by
placing an X in the appropriate box opposite the resolutions. (Continued and to be marked, dated and signed, on the other side) LIMITED FOR 9903 - Kazia Therapeutics Limited would like to inform you that the Annual Report for the year ended 27512
June 30, 2022 will be available for viewing on the company&#146;s website. The link to their 8016 TABULATOR THERAPEUTICS NC website is as follows: Box . . O CARY, http://www.Kaziatherapeutics.com/investorcentre/companyreports PROXY KAZIA P If you do
not have access to the internet and would like to obtain a hard copy, please write to: Proxy Services Corporation 10 Drew Court - Suite #3 Ronkonkoma, NY 11779 Attention: Annual Report You may also request for a hardcopy of the 2022 Annual Report by
calling the following toll free number: 1-800-555-2470. </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g402146g02g02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g402146g02g02.jpg
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M(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X #D%D;V)E &3
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M46$B Q/P<8&A,I&QP='A0O$C4F)RLC,$_]H # ,!  (1 Q$ /P#^_@
M
M
M
M
M
M
M                                                 &'Z%,OJY0;Q
M88LR1)*!I]EF8XRZ7[D"OHN%>OFAED>F+Q5+CA O3%^>?ES^GR!'^:NU_P#>
MEOMP5;-U3W'S[^:B"2AOC"6G.?D=,IC?'/\ *N_'/GHF7K^SHZ+?4_\ ^\!?
M8[Z\^PSS/YPVBS8T^S#4;);HRVM*UDC:O3BS2&S2ZVAB6/F26!X9BH66@V_3
M&XD?\D^&+_3\OGAC?Z>NNML\O[PA7G
M   '^=GZX_\ >3/M&QWU;Z:R.DVS"V],RWT!L.=U%"3Q9K(R2-9I>@6"NP24
MA(&LJ)G[U.,CDN*K=(3JI^=-\<^?@3+U3Z6EDOP8?A'_ +S+]JF@;KA]!L=N
MP96N7S9<JI-A29XDU:/%8&VWVOUZ939N^693K1V>-D5>)J\*;]9^\-\=^/@,
ME^EI)E_H^"O*
M                                              ".M?\ _J2ZC_\
MBZNW_P!#4F"SR_Q06*B?\)G_ -H3_P#96_\ \(O_ .J)_P"$1[G9+Z 3D[]P
MGB/G#E[WMTT/XYPW.][_ /22TW_H^08^K_\ SOX]7^KB*\8
M                    _P <;["E"<]]>W^=.3G>>N?1O.\Z;G]/_INV[_PB
M/=K_ !GY(Z\I*)_\U/EW_63_ .N3P3G_ (Q?^G6:A_X0+XK_ &?A7A
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M%&T2.(D<WZ:XW2DD8<O?U%D7?/\ 46L[XFV)X=5P8
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M.>-ZVFX9OX]\W36153,4Z:I"F+WG><Z!WW]ZW=!D
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MNG2(J7ARE[SG> SM>VUONVL!D
M       $3[GAV5>E<EO.%;A3V=_R?2H;_'[Q3G[V7C6<_#_RVS[^$X?0,A%2
M[8G\MFD?\D'"1_DGQ^7Q\\Z66RYGE$NF>%_)VQ7>D:/I&+5VSW?/,JNN&5BP
M.)"R,71<;T6 <U>ZYC/I14VP9W*DST(]714CYE-^W3,LHJD4BQS*=$VL\-83
M_2G]:+RN2=6GO.;BWQ,S0X/+)+MWV??;C(N,RJUK@KM4\]++V/49*4;4RJ6.
ML1Z\9&HK)M6)6I4T2$3,H4YK[F_NE>C?6#X;SMY4W]<Q)1RYHM@LEGJ/;AI^
MQZ*C 2]OS>9R&S&8-="T*T-21TWF]@>12['I#,3H+]-^G]O"J%)=]J]//WUD
M>)_+U]J6H8OD#ZNWV@4N=S6A6.:U+8+XXI&9V%=BX>YO4VE^OUFC8"A-5(Q#
MK*);()LF'4_ENFF8Q^F8+OM9B^&QVD>><:UV^XKJ&C4=C9[YYUM4[=L7L3J0
MFVCBBVFRUMW49R78MHR391\BM(5Q\JU,1\BZ2*4_Y%(4_.&X26SA%UQ\(>2]
M C_0,7<,:AIIAZHNF=:)OS=:=N#?FCW/)DZHEGD[(G96)LK%N*R2D17$DXXS
M-%7^&7]Q%/R4_,LVVF,>C%H;ZW_&-?WMQZ5A\:08ZFO=)_3"F3NFAGS]EJEJ
MC7<19=7BL?5MBF2P^H3L:_73=6!K"(RJIEE%>K_N444,.^V,>BW3?UE^)YO+
ML&QSF.N*[1?,+^PO\%1H^EZS0K/F?;@1^C<F-?T"FWJ$O_(BX,Y1PWE&:TFJ
MV?-U/UJD,4I.%';;-ONT\L/T;^5)7>\CL4-76M.\PY)YLV3&('!J9:=<I]DC
M+ILFRQ^L6&]UW6:MI,/<(2+D"+2[!]$D7,W=HRRJ??A#_L>QK[EQ??+:.]_5
M!]?VB,\ZC)SSQ#QD/F&:0.+5Z#H]OT7-X.5QRLNU9"#RG0(:@6^M1NHY]'R+
MA5P6*LB<JT,LX7,8ANN%_P!E2;[3U5>T?5;X']"W^V:7KGGR(M%FOM/J5%O"
M3:X:/5JQ;Z_0"HI4'EDI-/N$!3IB7HS9 J$/(KL3OXU O$VZR92EYPDWVG$K
M*+A];WB:^:S9MRM."P4AJ5SM>1WJUVA"QWJ)_P ANN$2T#.9-;96$AK3'UUW
M8Z9(UAAU%Z9IUPNDU(BX.LC\I]';;&/198'ZOO"-;V.9W>,\]USM]FI319\[
M:3GKI-Y[$677XQ_"ZO:JKD,S97^4T^TZ3$2CEM-2,7#-'D@BY6*JH;BRW[!W
MVQC/#*/.'U[>2?)UK5O&'9B^KMI)14<L@I:Q:+IVCJT;*6TLE.MLLS9'2;E;
M6N;YRWF6Z;DL-!D8,/V))_*?>))\(+MM?*+MJ^HKZ[O0^M7/=->\Z,[3J^AK
M0KBZW!MI6R55W8EJ[!Q];A%'["G:)7X;IHZ$BT&Z?X-B?Z2?/?DQC&Z)OM)B
M7A,E*\$^1LZT&NZI3,8AH/0*GH&WZG7K*C/7)TZCK_Z0@X"M[;9"-W]C=L%W
M5^A*LP0<)JHJ(-^-^&;)HG,<QA=MK,>BQ1_UQ^*8JH9-0H_!H%M4<,S[<,KR
MB%+8;P=&G4#TE'.8G;JVS74M!WCYM?HYVHDX5=J.'#;AOEJHAWX[P=]O?RLU
MA^L'P5;'-<=63S93)E2J^=X_R?%)OY*W+-%?/4/$+P<%FDZP[8^,;7%UQ@X-
MV,=2B;R1C7'PX:N$G!2J\'?;W]<K=$_5GX5B\DTK%'&(]L]*U^8IU@T1Y?=&
MU70M L$UG"J:V:R9-8NMXG=0AG>;*)<[7S1\NU_LW>G,T_4957IQWVSG/*9/
M-GC+S9Y%/HKCS[G/:._UV:A+)ITNZM]ZNDY>;'7HC^Q1MAL<W?;-9Y:0G/[;
MWI7#HRW[WBG>JKF45[TX)=KMY;0@@                              /
MY9$_LB]38Q8?1=JC]#G-L2@K9Z+K%CI&GT$C_/<&OL'[QN&4^=:VVEJ3 9Q(
M0+&_>=XARN5O-6(R#@[%F_\ Y)#.DT7D=>LLGI_X9I1OM?\ :;6\P\5-Y_F]
MDCM;W& 7C(ZS5RXU,F19K:L2\;7..S1G*QARRMFG?G=;-/M9)6+D7CIM4Y1/
MK0K8JB\/3IK^/U?T3Y-:W=[RO,[P_?5N4?7+/Z;:WDG3>37*A(N[%7(V7</J
MIRR,X^Q<K;M9YU1C_/;H/?XIB?O3(K^1>'.\7"0 1H5]F-OWBD^.[U+^9+0X
MIFZ2%^\^5#/K(A#,I]./D[]Z'RRCO"R,7(1\FT6@WL187#>0.9'Y09*JJE.F
M8G%"FM,7;GPXU8[]N/MR7KCMLTQ..LUJD#>C[W$T_4:G?(K1G=<KUK]BW5 T
M4:L-X6NH9]AT9A,'GCHBR*TG(35BCENNN'.DD_.ETU]_QPD" ^X+V5;9E^A%
M^:<YK\18:-E]^SC_ "N-TM&?/3=RU#((S+M L4&VDB2CBN?[?ZV1G+MR-V'6
MUDBG/ZW9^%7CVI.FONB>V_;9[E9V7,I^3IN:5DT 2W2DC1H6EZNO4]N-)5"V
M,*UF'3.FLQ:8;29B[9ZORLN6SI-@1><;(/$7?Z/ER7IJW'\Y_91Z^WKU/6\0
M>X/F.>TZ2VW9*K99B=1T!U:Z=2,C[9#.ZC+H,9!6$:ZO(,81B\2<.SLVBC:9
M2/V/332;JR1FZ2:YRBKVIZ=]J9;J/JRJ5W89&+SVO[SY?BX*U(5N#SF*R3)+
M_P"<O1NARL.CH*N6[7PKV=U^D5>'6G'D+*&<.I)".(@RXZ*H6+K-;CCG"8/7
MWMZ67\&8?JF<[U><0U^YVNIY5)LU:]08Z:AO0TIE$N]DZ3Z#LMNILE4,CIN-
MW)0M@O;EG#?F\;P2D/'I\5D4$3U-=?FLLX<W+9[T]E1L/HC:S^K;U4[A(SO^
M(1BK'.\\JF<U+TK);1ZZH>=U.0O-OS:09YCYTC<.SNF:=8^/^3DU+Q"2*+)?
MBM@12<1J:Z^W'_AUK^MWT#HVV[UZWC)CTNMN>>9T_@JA&,+)6Z;3)]32XNX:
M&E?[MG5&K,.SFZ;YY_M9X:M5PTX_E']B>U]_,)G3;.TE'58VDDG'+L0#
M                                                      U:]P26
MC0OCKT_-Y):8VDZ)!X5ITY6+9*,)>10@74-4I23=2#9&!GJU+(3"4:U6Y'N4
M7J76;[J+CI52IF2.:UQVF?&7!7RC[8^Q&Z9'Y4\\9_J_F\^F5OZJ\V]^:-N_
MH&DZ==EM)KMJ<JUC/\R>I(;!!R2EG8-X!96_WM9^Y*>0<I*-HMO^?4^F[KKF
MWG&<)P]W>N;-Z>_]W3O?L>O,9K'K;KWG'(-()'0EGE(1[49J:TS/$I5M$6Z/
M/'RJ,&HZ_?QN]Y^LZT:J4Y^?!S%Z]#77K]7K\41;Y]M'MSQQH&D^:=4@O.^V
M;%:*[X]LWG_0L,S_ %)W2:*CZFUBPY+(UO3,[+?+)<-$D:<I5U7];+&242[M
M_5T$?P:F6Y^LLTUVF9G'+J?];7J#T=Z&K^[5KTUF;^H7/$M4:TZN7Y;*[7AC
M/9*+/5.'M4#;E<9O=GN-OS.R1RK]=C)1KJ1=)G_4B[;G_0Z(4IC;63&'!GQ=
M]A/K/Q_YZ\JW:\+4+8O-&R>COLLH$A5':&A3/I%"3QZ>]1;7#61'3)RWOZVM
M'++YFM MX3D*8C*,Z@<KDY^]3;QTVUFULGG$6;>?LL]U[Q]?WJXVKY\\JU$V
MSZUM%]+9SKF<XSK_ )_)BUS8\I<I&YK"7N[7Z>6W.L3%3MZ:K"[P2,.GU^VZ
M0[8J+QMTJDTUFTD]\>6<?8C[#]>:WX\^S.KYU<LJR[#?%4/Y=PZQMGB>@L?2
MVA6V\UW"M&F-,K&E0=^A8VBQ_'-T;Q\*R4B)$UA22><.Z0.<G"U-==9M/>M[
MOO?B=IM^7_71GN [!8L1UC2?L!QNJ4[0H26F6"$9:%<NU>7K!K.UB'C4\_5C
MV>*9]?LG'%FZR/.].DI\<+TS]*R6V^,.9N6?;)L<7KOV5^I4J8ZC-NIN-?6K
MYLM>!:G,6MCDV&>NK=M-_P#/FIKS[)"0YQEG=8NDH657D(_J"\O$$:EZN113
M]B<;OTYQ/2Y;^Z/]G?L_REI>RY+O?/.FJL_*6E>%KOZ!VG.Z%>:)")^1_7MR
MM&8W*3/2I+3;>>CZGC-PCV4J5=:3DH^2K"IUSM$5"].#,TUVYF><_P!8BN2^
MXSVAI[[(:MB6=TZ*D?1#;U[Z R&T0GG+9?1SUUY9Q/9FF,X,P>YKG^B5F8>V
M?6WJ2DY/6<KUO%PL*_8<0CU%G!#"G36>?3"FTC[@OL D*1IUOHN5^?\ %9/"
M?K"S+[!=3H.P5?0+K9U+:6_ZI5-(QVOR%8T*MQ3> LK;.?W0\RNFLNP053ZH
MBY,OTS6+--?>\W"#O=_NWV?:_,_M;%-CF\?B;)!8#];/LO([OAG-&RGE/A_0
MWKBEU:0R"[S\K<[!*33"O'@^)N+$T[%_SH]=?JK%,JG$4RZZZYEGQG[-D=X^
MVKV[Y6U_6_'^D0&%:YO;_0_'\)C>LXIDFJRM'J5>]7KZ<63BKKB3;19^\7F_
MT%++7?:[%L)V/7M97S4ZG\7GYE-69IKM,\XY71A]G7V569_YOP*!R3&*1OFS
M>M_0GF,NC;SDVLYO3K'1<YP)CM=+W=EC'-$=7NBS2+%XNC+U*0E'9UWK(J:+
MML@[372'73F^F'6C[ (/T:Z\*:ZYR7T*WP;7*7CUNN-LTVKYM'VU6:;5+,[)
M(VN"ID78I]M_@;NRRJ!#L9CBSY[#$3YU,BBOPH4QKCMS.'\W%RNWI3TA$?6Y
M@*)+3J].C?I&JGL>8KUC]E:?Y21NNLE3JM9LFDVS8:&RL&@Z)?Z# ((F@F3S
MIXUK*SJDK**<11[^4=>)F^O;'C+^F#ZY?0-(]%>,/,>@56W7:Q.[)@>76A^U
MU^SURS;@V:3->128R>IOJ['P;66GIA1@L?LN2.9(3/2]=I)\XIWG*Y;RS:_F
MXB6VFZC8_L?FICS'Z+WCT!Z(Q_UG.ZEZKTUG>KI4_)'G7R>C2I8]6^O ^7N+
MO)YOIVP6 I8_OZH:,/,LWJZLI)+,#\*D#IQTYDQCCWS[M/,5G]5A\I^LS?*/
M[8U7,MQ^S#SU[R>>Q]HTK5+9I- HZU6QJV:07;TLNMMR:42@+>6;E%)QL;V'
M+!H,D/AHOTWSTIHU<7,QQ,823G-,+&8+ZFV6%]D^K/+'U26BO>4F;'4MLT/5
MKMOWJV:J%]D5_0.D>?8*P75]M.,1'KV'<1E8AS,E$I.;6<'=L8LJ)T2@E\R8
MEWY_'Z.UGT^9SN.?8=KZ^G--8IN47C?[==_)6*;Y?Y'3-OQ'SA+P582JU0TF
MS35@MDY&RTQ/-9*90@7LI(.X!K()M%UNK%4(2N>]EO'G#K8#
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M#UXR,10RCF,3ZYX3B95/UDNMGEMZ#(
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MW=GN4M+VSKB2R=UV$?3M:T&8@G;.+_@QJC%UQ7C<KI,BP)=[>/1UL!@
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MW*QIGMQ.7\RU;SJ@FYAT1))TW#?KA]H?:)AYK#XFA-]BKY 8QEL1Y@TG_;V
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MA/K5IU+)J*_SOSX3;KZ.CX,@
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M<YSG 95P
M
M
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M.?V))G(10Q!BIDYWG><[SOSSO]>=Y_7G>=_Z> @
M
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M_8+&=-[OH=R) R3:2=<ZR=QCTJ*JYR%+RI=.+7=<',
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M'_8L9!F@FW2ZLI\%_8KU-/GY&^.?/?Z@PK@
M               %&\D8^/\ T]D'[-CQRJ5!O_,=(-OY"YO_ !44?W')^U4W
M_04OSWH"L                                             4$K%1<
M[%R4)-QK"9A9E@\BI>(E6;>1BY6+D6ZC20C9*/=IK-'S!\T6.DLBJ0R:J9NE
M-SO.]X CB6PC#YZ693T[C64S4Y&/$I"-FI;/*C(RT>_0B(>OH/F4B\AUGC1X
MC UV/8D53.4Y6C%NCSOZT4RE+FK3$>:?.-?A_P#'H#S_ (G"0'\E%Y_8XC*J
M)&P_\QLE-(-W7]L90*++^2@A9)$A#_A^12/W/.=YQ=7\AF^Z_0>)8S6(QI"U
MK(\QKT,P1@&[&)@Z#58F,9H52SN;M5T&C!A$MVK=&MW-ZM+L"D)PK.46.Z1X
M1<QE.C-2<"                                               ^3<
M-TIN$-PI^E[PINE_+A3=Y_I-TOR7\N<[_P!'SSY <O<XTGT%/^H(?*]7M]3M
M4GG&FW!^ZJ-=\_Z-GAXW-5LUM#&CZZ?54]KLF>S"5D?RO&W()9D_7[_+-SK5
M!S'F>)QNR8S'405@                               !_.1JWVY>3LC]
M!V+&+G*>PG^VS,,?;Y.=Q^98GSNJ9O=C.7>*1)8.]:$SJ,BYE<_;0YU_X%=>
MMT'<A^;E;G3.#)G6:6S/&')?(?M#]?>X/46KYCH/GVH1\3EN2ZCO$99KCLR%
M;>53!,Z>=<-5[A(4JD7?.7=Q?,')".747'135P]24^4DDR\[SII]6Z3&)A/J
M?0UL[9N7](^>^QK-2/JNN_L%[3I.5L&0>?+GK3.@WN7+'S"R=9S[FA0U,ML]
M&)S!&[]@Q=HQKMTBFMTID>F_#IN=*,[^<XQF9<])STSGG&7.?0/_ 'AI_5O$
MGD#T3!^;H^7W/T'M-LR?4\+?7B68L\1:9A:(^J:?9Y&PIU->2?MHE_<JJ=D1
M9BU*X)8D/R.7OQ^6,NWVOFLSPW[U#[3F6=?9GFOA4N7&E<NGR4G/]-]$_P!\
M70CLS]*;+4=$T+"\4=09(I9J\>Z%2\W7<%7,\1.DM(-"<3[^?R:L=+U[(TQK
M[;;AJ7IS(L =XC6H:.TSW+]AGD1U9F]XE'CV(A_$M(B+;!7A",5K3=!Y)Z"M
M)]0=L3+)I1Q2<,FLOWOQPMTQ,_"7^KN #F
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M8V:_PI926.V5DG3*OW^SP<9U\LT:LFZ[E*,CD4S*<2)T_2_EWGSWO>YHDH
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M<A9Y0UC.W:LSR4G+VJ:E)SIF3)JR;LNM9MXX0_1Q(G4?U?@;GY%[T2^52,(
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M:W-*@3I34_CYW#4>VMGR29.,/YQ)(A#?S55OR-\X]'5D&
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MISZC'[%_N+(S4XP3FGKIF4Y8J3D$^LR,^M7+DZ?]?@[G Y@
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M]IN[MQ(.9==U;9^$BF,K8W"\L]6='.\56,9RLHKWO3G,;HS;Q?"5P0
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M_P!31,_\)HE^XRJW[%3G.LW
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M3R9EW+:-:),T%Y27D5G#^3D%4T>&6<+'.JLIWIC=Z;O>@B\@
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M+K,#
M                        "PVKDF:L6,L*9V29[ S'(D[!)JN^+)]CW'&!
MF2#YY',EG977X=3*LX02,?XX=0A?DW UL\>.]";Y4VJVE1^@&G:\[>ECK;HC
M.Y-+%>*ZXD7S>.L$ZUN]POTQ V1=TP<<<Q1I9R1LA_'71*BV=()$+MC/#6KV
M!IWJ3+=FCM/SN"MBF'T:G0.>6,K1 MBB).TZY8EE']\1S)KUC)W=UG':[ ,6
M2Z<FSZW5G7Z/$EBJ',0UK)9B^6-TST+[PO-BF8*$SR!XO4[-*0MP_NN</HN.
MB5XC$XK2:3 )R[G14VZTUJD_*)L9HW.&)3E%T$3<7.IQ0PQK/*AE]Z^QUI7+
M4YB<82E>1T(6;ID\META&35I-)6)>OPD'.T7E[DI2LR[7M4>/9,J9'?48Z>C
M3_BEPKA5 8U]V5V*Y>XF.$9K&U*JV9/0[I7-K7M#^3K/+'9JW8GUW,2D1SIZ
MZL#!I3TH#/9I_*QCAVD^(\>PK&,-PIW/"JCY<_!;)^2]PTG2JM-UJ"O%ASJ$
MQW,,.G'LJX4N!^W)9E3[]H?H-;*DG3>9MDY#0RDE")K<FNJ.Y9+K3]"O3?M.
M/EQ\4%1\S]DDC%0"+M+5X28B\@JD3)O$:3U<T5-0<38Y%>RFX]M[V(T*_P!\
M9MFAI1!1N8L2\=_P2$,Y2(MR+\F4TQ6N?8HFUCHQIE+=KV,K1Y*4--T*5ES]
M=0.5/[+78)I/OM,XYL$EJ5R9]CY-8WRM65^)MS<75<$5Y4QHMT;</=^FPGJ
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M),BOXK-6(-V3KGU=5 8
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MQKV5>G(Z13<(K'00ZX5*X3-VRSX_E'2@&
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M)_+Y'N=2EG;A(Z7Y/.\:I=43X@8RP[G/JXS1;G$I*_SLDT;P%GB8]->IT_\
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M,ZBVN,1ZJLKGL+#OS=BVJ3>CE129]_24I$^?S>F[9UQG\?T=/@8
M
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M5UAH=SU[$1-M<1#-6R1D4\,=0SN-83)UDD%>F-U1(A3?/?GY!QOP94
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MSAKK(VRW/5^J.7Y7J:Q/@I4NID(0I1VN>WJIKQ]>7D[1D-P;6W.G\BEZ+K.
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M7.=!H&+V-6XY+5-IH\-:&M?V6,S^WN%9-AVQHR"W7BRAESK%4,7I>^S<"_\
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MJ5ZF)O6CJ]V*PN(=%2#J[3BK=H9!NLYXHY.0SA990YFVWRG@$
M                                                 <8Z##UM+[)Y
MQVW1H1-3/I.@O+39&I,.)6)G-#92[1KM.JZ<=5T->[Z-@U7$<XG_ .0^,Y+"
MHOU5EU(Y=FS0CI?X?!V<%<P
M
M                                     <L5<^\US_I!M6JYZ>])0.@'
MVK0=)A<^K$BY)EM?U9S7[+$7IO'2$KD\I5V)YR,3LZ23-Q*G([?-YW^'\O6C
MW]!O-QS(ZG P
M
M                         /-;OPDKW]O4?A,_?W<_#Y2_T]_[7G["F3^4
M_P#C_JYWG]/Z\^ '%7S1+Y;?/9]@M=(T7+K)_P#3&MRCM-]H&)$TJ^6>N9E(
MUD^D0N>4WSDPEUHR2CY=\X;.FET2^&L@^<J$*=T\9J'2_P 7:X',
M
M
M      ',K!'_ )-?:X@AG5P]8WR\M]EV-=&/T"=]=S>>U6ZD5O*-W?+L;U_&
MR=A68S]\@QB5W!542'>-DVIC+J(FX;O;'IC'P=-08
M
M                                                       !QDKT
M9 U[[&(GLC8E[',6'8M$-5^16KY18Y^G(N,>T&=GZ[::)%2:NEQ-2L"YN=<+
MKM"<0+!5E@OU-)DFJZ-_]79L&
M
M                                      !\G)Q0ATS=-PIRF)WI#F3/
MSAN=YWI5"=*<AOCO].\[SO._\ '.2(H6%7S8;-!4VO>Q8^=C[!+52:VJO:SO
M$%GK*T4UBW_NK TO(ZD1E,&9R$61FOQ6(>1S^0*8JO[^&4/TUSCT='09
M                      !Q[^SGVMM_E_6O(N99#8ZG3V.]0_IJ3L]DF_-N
MQ>J)Y.2QFHT"?ID#6\OQ&TUNY*I663LZ[9\]*5PDT3_6H;\.%[TQO767-KG-
M<?MX]^5NXV!M9L[SO)['GU!^NJ8N&$VKSKLMG@F5_P#7:,*TTRGZMZEB='BJ
M!YA:5*5D3_VIS:(UQW\O^P6XNJ@K^4;Z:X_K^S:9/['?7#R/A?32;+SRW\N6
M[WV[\$Q6&(5R[N_3\(LOZ%E?+\7JCJX*7DE2E;\UOL?RP.J)RM(?%4_+O)/C
M@O5>UGIKXY[8RCC%?LH]\>A(7V0UR^-\K631OKP;-ZYH-0@F]GD6OL*Y5/4+
M5V]VW%GJEV04S7+[7D="?1-=<N_[V8FB'>,W"QVD4?\ D1;KK,9SB_LZ)>0M
MZ]1>U/*-P])5Q3/,-1WJ5?6OQ7'W?.YJY/J?@YTHUI0KINM=B])KW;5;M)1:
MO)WL=%RD4A%QTBR;]56626.>L636XOZN/5O^XCV;C?A+*?1E^N?D&R[1Z-U[
M78C**&_HUJQVFU[+O(UDV1+T"K-6*Q;7936VZ:5&9K%1-110_MI6EALK-LHF
M^^?D'3IK=L<XB5_3'V]^BZOLEYL/GU"BS/F.C8'X6]#-)FQX%H=S@)"A^J[)
M92VJ>UW=:KJ<'%8#6:Q0X(TFRD%JW/?L.W<\.B<J!N=B326<^<W]FRU*^Q[<
M;+4?-,XJPS%1]K_V^;UX5LB3.$F>$3Q/,[3Z9C*]+0S?MH47:WQ6%R*(7=OE
M?W,S\674*S3(JGQ.G2<__CE4I_9S?:[],V;>^+WW)H7>]<HE.A*3'S)WM4R
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M_<N=!\ZZC:+A?,MEHV1N*C1F=X\XE-QZ23YND1)3G3UG>28QZQTS!@
M
M                    '(JE5Y+,O?+Y[.T>DNR;#L6@?XIHCC-,>6T*/EE\
MBFIX\ :_5?U"_P!')$*Q-0?<;N97.N+)M_A@L=NEULMPZ?\ 7]'74',
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MR)]Z@W)PWY=+SH)F^$A@@
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MYN&AGMK2D7#!F[Z19!LJ7_00IBEYRW\SWQRWK^S:48:
M
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MT54IR%KL_%N^G:_DJR?L6KQH<W4U"=Z7\C9VF+A9<S*4A%
M
M                    !R6S?B3;WC:&EG06ISQ73[^[JV?IU>Z.*3-.EZ$]
M7::I$2;_ ']S2(S0K;6NK+2+YM06CM4IW+?ACE54D7)N_P 76D&
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M&3R$#-QTLK#2!>GYUE)IL'*YV3G\DC\_!3A>_)#<_P")>_"RSRN964B
M
M                         YG5')?**OLM2]4.TW5?7H:_7V5M;*(RQ23I
MKV\NJM;&<O#36X)Y&I_!+6&MYFC*17+<3AGKE%DX*<L>P9-S=NW7%\.F(,
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M4I1(^%A#5S/5DYKJK=@_XXD?Y:RIU#E+PO#9VLLQ/=J3%;<C#0
M
M                 #\[WG.=[WO.<YSO>][WXYSG/Z][WO?Z<YS@#DEF,Q)L
MO<\\RA?[ZR3L>JZ"O8LQCI'T@2GQ],6SF0D8GT*>T.]9=^:[0ZO<XS8M35YE
M6DW+5:3_ &\X5[&O'*AN_P 76X&
M
M                                        !\F*4Y3$.4IR'+TIR&YP
MQ3%-SX,4Q>_/#%-SOQWG?^(#A=C462A>]X.CNX*T/4S;%KRE:MEG_P!A*K8G
M; M$TQ<[6/JN<^3ZW>I+.*9&(,6#3BM^XQ0CI2#<.$>G629)G2\Z_C_;NF#F
M
M
M             /DQBD*8YS%(0A>F,8W>%*4I>?)C&-WXX4I><^>][_P <E,G
MEYB/]O6=&M+71.NV_7-$6L67L;7M+^'@XPN=.7[+T)*)O4E<.[0="EV+5LTC
MHQ-M^,G*-G'7KF33D&I#=_BZV@P
M
M                                        /DY"*$.FH0JB:A3$.0Y>
M&(<AN=*8ARFYTIBF+WX[SO\ 3O '#[S&QSC(O;%ORBF9)E</2T-EOC:@WB%8
M6>$LT1*VVJZC.R]+80!9EQ$*MX:7S>R-.OC1L>R(Q(BDCQ7G4'3B.EYUS?.'
M<,5S
M
M                  !R23SCT?4_9,MO#7SC8[8ZD=)M-6G;U"V#RC&P$]YS
M/4'K.@-H1E,.('7V-OAK4K'J2"[V3_<NW9O"\ZJV69L6YO,ZXS_=UM!@
M
M
M          ')_.>Z]*^][@]9Z%I5DR9M<9EL]E"1F^J40CVM5S2X]_DQHV3K
M37!(.-KTA:HLBDO'22ZSN2K*13)?SWCHZ9O$Z_%U@!@
M
M                                                        ?)RE
M.4Q#<^2G+TIN?UY\E-SO.\^>?'>?/.@.7OGSQW!8_KS'0D=JQMYQ36M0<,:_
M1,\4J\]//9:*M\8RSN6L4GLES0FIJG5Y/AGYR119AP:%^5%4TTUN=-W;,QAU
M$!@
M
M                 ');./(VGYA[29Z16\QR:N9)(:/IEG=/J%F?G.N%B86R
MUB]]5>R5I-2$_03JUV^QV.'46(SE#LU'C>7_ )!D6"C%!0W=I=<>KK2#
M
M
M          ^%#\2344-_XJ9#'[_4I?Z$+TW?ZG,4G/Z<_P"/>\Y_U] <5<YW
M;4M@]+RB>.:VWRR.LTK/R,!FL_IN'^CJC=SQ$.XE%'5OBV/IFQ7C*VC\T>J7
ML7GL5_':]/QRX7Z7BY1'3$DY_'[.UHKF
M
M                                             /-4W2)*'*D=8Q$S
MF*BG^'%%NE+WO$B=5.FG^:G>?'/R,4OSW^O>< <>L3E":[Z\A-!@*9JV/(P-
MYT![.0-LJ?L"(E9QDE1[13U:[<Z_:%^^9ZK"JSK@DBSD&)W*2[F,0)'_ .IT
M=01N\:XX=B16
M
M                           <5<R@::Q^RVZJ621D8"XNM'GY"K5])]@$
MJ^M3IAG.C2$?/2UK9:5_OT:N*5/1Y5).O/*JC_!_M\>7CM6+9MC&.G_1VJ!S
M
M
M              !R-J-3J2?N*.DXR@7>NWAINVN/['7FS.Q\B?\ #%\OMJU8
MW2?M<CF)89]7I^V6V=;M8R/LQ&W%K2V35ZX<QW6+,W;\KKD#
M
M
M   .5V>^J]8MGM&2S1.^9I.Y(_O4S58-O 3F0R$+UG5*UKB\W"04M%:&_P!6
MEM58R=:@5Y1@ZA4VK+A9=/\ %-!L@Z7-X^7/JZH@P
M
M                                                       #BYCS
M!(OON>:4_8,VCFE>V75D+ABT?)Y[G,^T:FI%LDBD89?$9#&72]+61:VQ$FM+
M?Y4Z:&6A'K]U^Q=X1FR.E_B[1@Y@
M
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M[:^Y_P ]]G_[LEU_]9F2?^DP=-CMK[G_ #WV?_NR77_UF9)_Z3!TV.VON?\
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MARG*?\BF+SX^>YLQ<'Y)X$
M
M              '!YADM"M_V46.)NU*P.=Y8- G[>V>)J8THN[4K5,N#>?2@
MVD2Z_P![";4@FXIAIA>0*1NHW8RZ::AF:*;<ATS9KP[P@YN;GN?_ .J9YM_^
M3=Q__!5 &]/Y?HFW\?U_VUI'9S                 &YG@?_P"<C:O_ +(:
MV_\ T#YN.&_\JZSQ&]HR
M
M            .:E(F_(Y/7%BBJ]1M-;:DYU=93ETD9*QK9<_U+E+W)"19UJ&
M=75R@P+&MXF_]4YR$:Q?][D)!TD91R[*X,:N<?!TK!ES<]S_ /U3/-O_ ,F[
MC_\ @J@#>G\OT3;^/Z_[:TCLY@                #<SP/_ /.1M7_V0UM_
M^@?-QPW_ )5UGB-[1D
M
M          <1Z$LQ6^SF6L)[!77ML7T:WT4TS7,?M:3>:I'^W.H2/^+6C2E\
M(AJ<6SUN5H[.)8<;W-ZN16M3W3*K*22D:Q.E_B[< YN;GN?_ .J9YM_^3=Q_
M_!5 &]/Y?HFW\?U_VUI'9S                 &YG@?_P"<C:O_ +(:V_\
MT#YN.&_\JZSQ&]HR
M
M       ^3&*0ICG-PI"%Z8QC=YPI2EY\F,;O?Z<YSG/Z@.(^6V>+OGV-DEXB
M7PFT17^0V&RT^;J-NPQS'KUQ_1M.C)MQ78BMVT^P6#67*/\ CJC]U*Q:S5FD
M:?ZV51;..=<QTO\ !VZ%<W-SW/\ _5,\V_\ R;N/_P""J -Z?R_1-OX_K_MK
M2.SF                 -S/ _\ \Y&U?_9#6W_Z!\W'#?\ E76>(WM&0
M
M                                               %'().EV#Y!BOQ
MJ]69N4F;GO/GC=THB<C=?O/@WSQ)7O#?'QW_ ( .;WBK&O5."3;ZM7VAY@AG
M-IB*>ZM$[$^H-4U.R(Z3 5-_'7?0V=;ON*PJ3I[KEB39.I! DRR3:G(HOWCA
M8Q_VF]KK>9Y=+08:\;MYPK>]/*1)R]TO]'EJ">R?V>3H3FHI+N6]J:1S2792
M:%QIURCUVYRQ2!T^IHHK)G)_0_X],7MELN9Y/3%\(2_Y!Z]_WA/0W_EL*_\
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MBA'=00*FS6BW]RNZKET1P10_5^.DRF*<I?U<Z3IC$_)F0
M                    (OO+7:5Y)H;-9S+XN'XQ_%^C>:K;)Z24DOWJ]_:T
M<P%RKC5%C_%Z3GZSHJ*?LX;OY_'>%X68]6%?V_U=_P#]?YZ_]7.D?^U,3E?E
M^+PI]PV./V!CFVF.<SF&$YFUGO$7)46!M5?>L7E7M%,@5F,@A8+/96[UJ_1M
M_%"'3,B=([?O.\-P_/QJ7&.&Q@(
M                                                         "$?
M3/\ ];?Z"_\ Q(ZO_P#0'/ L\Q+<+_\ P>)_^3&'_P"ZI 7RN8(
M                               U^E/_ *ZFB_\ V/VK_P#]QL8!?3]6
MP((
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M<O.\*<R*)$^FYSO]><-TOR"*L
M     !!4G'2!_3-*EB,'IHIOA6GQR\H5JN:.0D'=_P B<M&"SWA.MDGKILR6
M432,;ASD1.8O.\(;O"^B=00
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MS6U0,@
M
M
M
M                              "V,9J&DV?9&-EHR0C^*G0Z^8OVKMGQ
M9(_ZE$>ND%5$.*IJ_P"DQ?R^>&_IW^H"O.JDGU,JBB9#*G_6EPYREZH?XZ;\
M$^&[SIS_ (\[WXY_7XX IRR,><_ZR/V9U/\ 5S\"ND#'_P!/.]-_IX?O?]/"
M][W_ *O@![=<M^%2/U='A%^?DB?JI.%6+^'5?E(WY?"G/U\Z;^GS_IY\_P#
M!Y)2#!<Y4T7K190WS^*:3E%0YOCG3=_$I#]-WX+SY_\ S *L
M
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M3/5%KD4U)G5H>T/&)FWF3C]P5U'INE6T2_;'2_0>*+*1=9)IFX]7]48KB
M
M
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MR^>)J&+S^AN\Z%<
M
M
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M9W-4.,=W:,KLKW/8N-TK'=$V^GVU:W/DF,?+5B3J&:O$OVQ?\]P5\Y:I]1_
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M35R@H8BB:A3$4(;I3<[SO> 63%X?[#PKQ
M
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MG*23UQ64V[*/CF+=19=90Q4TDB&,;O.<[T"[:XO,?ZVPKQ
M
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M0N=M9/#2MHZNXCDVO&Q6,>9-NKURJ0S@YC:S:Y;D@R
M
M
M                                          A#TO+2D#YXW";@Y%]#
MS,3E5[D8J5C'*S*1C9!G6Y%=H^8O&YR+M7;9<A3IJ$-PQ#<YWG?D%U\IO!
M                                       !#\A;IU#?JG0TG*1:S*X_
MH5N?,^M43+J3L!=,QAHMR5[TO\A-)"/LKPADB]_ _5.&[SY(7X+CC/Q3 "
M
M                             @#U;_\ 6R>@/_Q.Z)_]"LF"Z^4_@@
M                                       UZE?_ *ZZA?\ V/6M_P#]
MR,3$]6O^OZMA160              6>>?R<9%.GL/!N;)(H_I_CPS1['1SAY
M^:Z::GX/)9RT8(_H2.93OYJ%_+A/CGR;O. (\_SG2/SX7_9*P_C\E^3_ .9Y
M]\<YWG/GOX_Y!^7^GO?_ - +P^>7K2>\[WN(6'G><^><_P TSWOY=^><_'YY
M8?CGQSO>_P#V@'[_ )UI/X_/^R-A^?R[S\?\TSWY^.<YWAOG_(?CX[WO>?\
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M*DU"R+@C@RC*R2;11 Z:J742=O@Z$@R
M
M
M
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M5+JB?YC'P;4_VO:OGGQ>LN^/@OY<_P!J;9WO>_\ PN\[_O-S\>=_Z/Z=^/\
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MXT7>H4@B#Q9T8QBR<S/_ *4%(HPLF%HO^T?8'5;Y<F=2R"8OM6K>UWVUU_\
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M1L(^2GV,[93MXAF0DA&%8G3DR_O(G^(LD\-XP9
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M2220)Q-%)-%/ACFX1(A4R<,H<RBAN%)SA?R.H?IN]_Z>][WO]0'H
M           #X4235+PJJ9%"\.FIPJA"G+Q1%0JJ2G.&YWG#I*DX8O?^)3<Y
MWG]> /L
M
M
M
M
;                                 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g402146g03g03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g402146g03g03.jpg
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M(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X #D%D;V)E &3
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MA>TB6<2VJV%E1EUMM.//T]24>X8N$4-]/$TM%O\ '<W&,9PN:>^5_P 8"PE
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M=Q,_VVZTYY8]-]=J<CEQO'=\]+9^1SY"&-T_(ZVH*@_*UC4E\<$J'.#H>-K
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M2C$%NE%.ZG+G>3/-C?"H\LQ[ZM"9?VK;,/Y@]H>CGGH^]_/0]5=-)*SLZ^E
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M&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M5%;ZN>VHZ>?&'M=?+3Y[D8+@J$1*QB,0E9X-"0PVE7E45L$G5B&]1P=\,0J
M*+3LX,C6CJ!J>8[E)A]([8QC%5MTPY<+2*K9HL.E1<V^5@:GJ>*[-\UU*?6H
MR"F]>-3XP<-@M4 J8P/CQF&Z!S?4=934A)IH=XVLYEG FG.Q<:T5:/-NUFJ^
MN\'37%:A]&>IR2A+4"12/JDFM4<FZ(] 7 01H$G Z-F.J7(J1:=*LW9B8!H>
MWA]P%C22JR3AQMX\>(-$&NM]=]\]$DS/F@N_D2KR57_D!2NK0E*N>%4!5D;Z
M <10PWJI&Y3(-B2H2!Y6-4,$+.28O'Y#'P3F83@NHAL1N^8[MURIRKVD.E^:
MG8+Y*R0GKFDB<?I$FEN2BP/'-77+:K9K!<TJ G_H/FFYRP1B.:N+ 0L]9,.%
M+2YX0E_XIY#M9E1NS<N%>^'.DR]==_5T(+Y?_.)/^H@,B-E%LN7]AJU.#04_
MITQ)K@BCPNAP8=E(J%'K9?.:[ZZ(2.,Z=,S7^M/F,?)(NUT>$TGVF8Z5KFWO
M3O\ JV; 0:'I>U[<M8[#"JQM5;6O^O52$:!P/H8;&4[/S!@>"(;KJ.F3&.C&
M;5K).74M(N=<-.%$N%EDC,F?.BIO*OK8F]179>' ^..HSSR&@E!SU3DT@/1K
M.2/NK@KQA9ZI&[E.;"D)N-Y3AIYJUXAG8U'K--H]]KNNEN^FJ);QQ/=2PK\G
MHSNX/544;)!;BFZC!+FL&HGU=3C(GM<NAO)4\V /4J)6):(>DVDA'GTDW_JR
M*:;3^2BTUENNNOM^_1>FDQNN7GY!19@:N@\RHJ\Z_0@+7%ZA.RHH;U=V. ,_
M8HHQ-JOD9SN LZ<DW\,9CTHVZ5[C&SY6#<+:2DTVN]=;T3KIG14HO\O'GTTZ
MB(X2!;/+RPX7 NZC" J3I8T);-A;,4EVXI.)I#-O24=7'*;J*YU+,C!Q 24(
M@];KO&Z27[/38O2K2#/>#<FF'HK!4_;=M3HN1%25JOJK$1M!A4(TG?\ :M(!
MZI%!S]F+D9?++/*KDUW28PG,.5H^-7D],VJ3AHSZ)U<F5^32H!TVLX$(Z[M:
M.G:[BTYII%L=U>2DQ=&]W2#4'QVV"!NS)0Q"7S\]L>([8,RIE!.Y"*<[=(I[
M_"NDF7I;,IX6>OY#CRKZ]NX=K><#+*\K"MV<SM9VIN!=Z:6#6-4(6I!L).1K
MHM(H.:&".!G8AYI>-E=J?K/>DNND7*:G"9,:R>*I\K]JV-Y6F1;?L)]4Y(!6
M-31A98<:TN+DM?RT:6 TU5T*YK:>$;%L<UAWG1LYMV-2AIK9#&LT'3=5)^DW
M1[X=<EZR_P#7=TA;Y/*Z/W"8Q6E+7):EIM>++<$M:5C*48;K"K&JHNI" @?/
MK"A[E5JB62F1^ZH->%3C)Q\O(.E%672:#Q!9'@G2S6[)5#_(Y49.ZB)T/ K:
M*J2=D-,A4]Z&BX0:2K</.+^@@2?K48FHB2+&-F.U'+:SQUO*/(^!>,89]--T
M'2O'?#S]0=;/Q0,:^3 5L\*B3:M*Z-N4'ME"X7&P,KS5Y/.FG10'V:3,!!!
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MH7O?;_E-"WQ)"2DIXA"8!K%-J7\@$7)DA(3!+/.K*FW(H+.84! -M&L,E!S
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M9==97\:;?C:A)M6E,(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M$=,QZSBZIVWF'SL,E))%K'$$.FQ'#1T'"3;*$EWK?<@[2CT]]JK*\?EZ,_\
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MU"]^LRN-C2 FK@%I.0_V"7QOGL?9]$O=BR<1^J/OH^2XBNY%X[=9%QQ]FK)
M>]K.N(@J#+,] -; L'_YZ\+QY=K:-9C7=/7D_)_)T6Y') =;007#%XR-MH3<
MGWI)[/#LLYZ57<=?K*(5/MVTQI_MHN@*Q#?:-< ?K/T(*O)]<X)I6XJ(%3J-
M8,G%24S-$=:%=8#*S'A#_HO,,Z>'B>4X745W_)OG"6^MH_3C"6];B*-!P8]M
M?R3\8\=TO8+9I'7^UD=E8?RZ2)QZCV=/^G1ZM21Q/ILGC@9:RU>R, RW*_\
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MO#EIQQIX?:S*YF P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M08/OW%4.F#SE$G6J1,/>7B6S:_FA*Q=G,H+V+'BD-$UN7T+<[8@O 6MA.?2
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MY L/(,# D@(UEM9\RA%'[A!!TVWO7U<(ZZ,XLQ[L]!_MOR%5 2/UT%B=F ?
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M\-3B4FHI*%T@55RZ;<L^4M*=JKHI);[6_(FF3K4OJZ]?/MX$!+Q4UAU_8A,
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ME]NP&I1>QXZE9Y24[JB-EHF7GVJKV <KJ\=H22:3;E,O?SY:Q\O>8O1E>W+
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MR6?EE7C3D66K> )]]# 0X)92&ZBOT!TC;:?,(?:VN6*O/#I%+CK7/>$S9K$
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MNWZDUTY24TCT.TWS]SZ%1CP_M&H["9%8.WKTHF'-R!$%"N)Q:7:OX"/(BP1
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M^HW+HF;*I*(N<\+J#'6(F6AX# K3:K062,FLKSKMLQ==[2_84+TD\Z1T+_\
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M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M1*RD?,%LB=3+L@D"HAFG1&13!;+N'KN7?].)5RHKOE1QTGKGC1+;=UTX0P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M! >G2Z2_4;3_  ]WPS>K,^NNFBG:'1KORW\KIM/X_O-UN\77_984QBGE^$]
MF9U*A5@EH7+M"?S$M"N*7F V1'I-BX"78BY'F:O.XW;?2ZB.NE/NWA)RL^2V
M*C\\0%.NH]Y%V/?9PO'"\D)\?[<O*R+30=,I,K<ERDI(-#&>DVCXF9O'6V;:
M34XZ>MXKGAEPIIMQRGHEN5_80P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!@SY'A>^2
M3S2Y6\Y&-MC%CC]IT9-ZAZ;U%\$1V*)W,",CD5EGCB%DI]D*;#7C][)=0[F,
M>]M6G?';C;7IPBJ:X8S]VV%4_(GU<]]^/C<4\^@]Q0MB-_4=$5[U'N6]@UM)
MD B+^H*R8606-YFO9F)/.Z/FP-*1<O)B(=-UW0Y^RJCOG?TPO#$Y:[8?.N?J
MKY.?&L_)(5=,69>::E40O3V5&W%C6.%4\+V!ZYF9LH#:>8VRK<!59!S4U5*-
MD(]Q-L"*:W%NU5.&*[9JW8\QK/#EO\:+!&O1/S"R!]5T805:406G]42#*P4.
M*)8S5><%SGRC9YZ+V)%.N48)XE,;O>&'H:3@Y RA>T9!TM&:B46ZK>7W2SA]
M4+C_ $M\U"D'3#:/IPND'#@U+(R<,BJIV,8E8,LQ**<X'XHS%VM6#A56=/2
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ME^R[^WZ-#>A'7L2U/B>'7]D!ENJ^A)2S*+>6*+4,P-Q.Y)JG87UR%*E3IG!
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MU:C7-CV"YK?:T>V@[?";EGIT?$HAHQ=*$0=J4ENXUXK%,GKTN.'G?'KY;/\
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M ,OR0"4 :K-M,7,G'N!V10X55X18O'+%9%JX75YYXZ+BXRT9A# 8# 8# 8#
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MP8V%%U>*:K>#AV;7I)S&P4LR1:)<=<]=.-:ZTI&O&'UVRL& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MV']LD_N[[Y[^TO+2X;XPR8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# H+U.CTY\YW,VX'H
M$K4<U_/MDAPF;(/H:757:=)),W,:XD8A*67[4[UMNR_;:]/'.DT.5D^E-=\E
MF[,7A"N!JM9NVHNM6-A2-7R+(+EFQS:=3S=.EDK83Z2.')V.MX"7#:XU-PD3
MVNT?[?<02/?$A*N4%7KY1/KEH7E]5'U-' M7>I(47A2VG[2FI^\+>X7@:Z]
MW%+6J".BA_8IQ*SYQ3_!5*5@UAQA=RI'2J"D?'-F:SA)1/K;G2:*T:NWE]BL
MKFS=ZQ "RSJ2(! +C5)29>S(>\[1C9"'ABYO%1)7#R<U(5R0$/2< .65'Q;5
M56#D'O7#9I(<)J==<_376BRXNJG_ (\P4I!Z.71)51J03E9UHM#3T*V@D9B9
M:P@F-"<G_:5QH=%81[(0A"/O(U!9%BEM1JSX[ZZ4^_2O9>5S6\<,F P& P&
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M=;5;;7UI92'?&T75S\>T%-55&UC8!O&F;)3U!5OIPM;O:]CEQ8FD*ZC@-H\
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MAA#PK9^AOMRY;[==[[T2\I9MK7T7PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MJ'F]<V!;-?0<U+*(N"6-BQT,+&I"F[<<]/54>V'73+OO[%^E>3,GW8L]5/\
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M[_S]WUP9=M)@Q;J]+H,VB*_>EM=+)-T4U>M.7'3MQKI3CCGO>EW7>U._KO\
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MX)VDUF^GT1D.^,:S8Z.L!W8I?2]KS5ET08KFXP3#9LS #'V-<SMNPOBUI+J
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M^>OM^G[;;Z_FX+-V4OCWL$7/PLF4 [JO2_1 =T/07]]N!H.0<4B3\H2,C.#
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M:G'/B>IPNP*^#SYU)HJ:<_O,Q:UR)/;/\>T?V'_"W'7/2'.NAVTPA(#\>@D
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M/#ZJ)<?B333^_M3\?'''Y%>OO4[^SG7/WJ=_37W=]?3Z[W_]=X8?O 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M P& P& P& P& P& P& P& P& P& P& P& P& P& P,;^K_.)%Z%*_*RT43D
M@/U'>)'8AQ.!9S.5Z>-Q^0\^796S!(0GQ]OV^_<<E1]'</$-K-N%HO;G6^]_
MX3[-<;C+%=R?%M#2+VUG-4BH3+;DJ+!( .D+=*BHL*3.R>?21Q>5_1EAFLXU
M)25&)]&#TLW'9Z:Y6>.>XY^X;;;;9(\ME#4Y^OJJ6Q?CKOV[G1X20U=4OYG9
MF-A<VE%5HP*G$RP;HA50P-;2E/&75=P<!#= GL]RGN.LWF+6503$(!ASRD\E
MU^5XXLYR>_Q^S25$5%(S'N6RY9"':P],U%_%W2D)L6DXG!A?M*\ZTCZWM$6'
M)E["PT 6Q(/5PMW+;>1J>DOY*QG?7?*:F_Q\&;?M]_V>B:^8O22WHD@,JV$!
MBL)\EO@)/5_2M7W69A0L2TW$S(NL4A]]^6%>98*MNVG8%$/1=M+=MNDW274?
M(?R$:LU_7X$LQBLE5S\5MP=.Z[&[,@H@@@ZS(JMC#N:+CFK)42] B@YZ1K2W
MRJ5<A@%Y_##(BW*1X,[DE>+!G9M^G+2:[+A1RB[?2"YJ\XTG8WQY6;,D/HR(
M$5*Y;5 \B22;\N!J[Z08]"1_Z!*JY)_1J<XS1@5HP;@V4E6"RX]VPTX[ZX,Y
M=OWPBGSQ^0SVFF=T!-_!E]%X+;M1Q]34A SSLEOPR0]7;)V'5IW?'6MZ$C+F
M85J[1[!9A48:&8:VV,&2A*U(X9--FUX9L'[/>N&Q>TW5,4?'/Z">C\L2C%2L
M.;%,)BT5H'@ZM3SV21@ \,A>GX)+5G5,Q\PQWG>>J\RG:J:R1 W$8EJ8MML$
M5F<HH\D7O34LY3+ZJ7O7-VM;8\]^CJL&Q.SRNI0FV:P/JPD27H"_M K<FZOE
MY0CKTDE&<U$QA.+EM21VTV<E^%N^B7KM/;Q)=-'2IB8Q96++D\N>LK6FB2R[
M2I#SM?)%;E%VQ1\56$^8)QHQY;0,S-[*ALLU)9@-?=6!I\*KL$C:8BF,?-*2
M,&SXC$%VO/':1J7C-LS'U5^2>(C*FHBF'#JE@3T[9T[\A2%HF,C,<I\/;*"1
MCR5;HF/$%BETL.2[*"DV<U&\/&#:4VK"HSSM!/;A-=WMQ@[9\XF$9_\ PZO0
M$>+VV-J4E0Y:Z]) 4@, LB^.$$&OQXK2MXW?:,7"UGM<&YDIT9KAE;,7)Q2@
MO_$.%"D;Y2TD@PTP=,QVGOI]4DN3XZ[H6K)0'K^LZA(YBQ9SWI,68:-G-:0A
M^_,O0UKSD[3Q62G5EU%93CD-0K6648D:4"P2)&;GEHWC7.V22_*@G*9S?9V5
MOCOO*? C03B(&KZ8)C\_K^S'EEC4_P +%;*4<_&\0^5RUI,['Q.,?R<Z$W6\
M5F$'O,FOS)M)MT[24;.]*\KCM,Y^-W6$?!5BF5M5:?$_G*@?/]< <KYUA2NC
MA$DBRX7/.*2'+^2<V2LSAPF$'WG,._LR)C!IN_0U*+1J3I5_MO\ B:-=#M,;
MVU]+_*-0RU%4PTK27:C[#J+LB^)Z'C!;?T@(D0/+WLD_!H>-;\L8Y&/1B0PG
M8-NFB*/#=GVET@C]R2?'6S'*YN6CL(8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M3O2G!-)QS9Y_PR4(_+6=OJI"SB?H*"UU,BWFB!>E*!N5)#L]=GHT%9'44R'
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g402146g04q07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g402146g04q07.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M"EEP#3EAJD(\S0J>.HSERIFO7,=H4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % $<L\5NF^:5(UZ9=@!^
MM-1<M$B92C!7D[&=K,9U/0KA+)UE)P1L8$'!!Q6]%^RJIST.7$KVU"2INYP^
MGZ5?7%_%&D,L3;@2Y4C9COFO5J581BVV>!1P]6=1))K]#OM3TBUU6)4N%(9?
MNNG#"O(I5I4G>)]'7PT*ZM,?IVF6NEP>5;(1G[S$Y+?6IJ5957>0Z-"%"/+
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M5E4=W8TIJRN>E5D:A0!Q'Q8_Y$*Y_P"NL?\ Z%6E/XB*GPGC7@K_ )';1?\
MKZC_ )UO+X681W1].5R'4% !0!YO\7O$0L-"CT>%\7%\<R 'E8P?ZGC\#6M.
M-W<RJ.RL>("-S$TH1C&I"EL< G.!G\#^5=!@>M_!OQ$-MSX?G?!&9K?)_P"^
ME'Z'\ZPJQZFU-]#URL38S-:T:+6($5G\N6,DH^,_A6]"LZ+\CDQ6%CB(I/1H
MIZ)X:72KC[3+-YLV" %& *UKXGVJY4M#'"X%4)<[=V7/$.FR:OH=S91,%D<
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M@/#VK&PO'QI]XP#,3@1/T#?3L?S[5-2-U=%0E9V/?58,H92"I&01T-<QT"T
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M*+0H1<6>L5B:F!XTT_4M5\*7MCI)7[3, N&;;E<C< >W%5%I.[)DFU9'C/\
MPJGQ;_SXQ?\ ?]/\:W]I$Q]G(/\ A5/BW_GQB_[_ *?XT>TB'LY#X_A/XK>5
M4:U@C4G!=IUPON<<T>TB'LY'T"HPH'I7,= M ',^/=$O/$'A.XL+!5:X9T95
M9MH.&YYJX-)W9,E=61YOX7^&OB73O$^FWMW;11V]O.LCMYRG '/05I*<6K&4
M8-,]NK W"@#R+Q_X(\3^(_%4MY:V\4EHL:1PGSE!  R<@_[1-;0G&*L8SBVS
MIOAQX,F\*Z=<2WXC_M"Y8;@ASL0=%S]<DX]O2IG+FV+A'EW.WK,LY;Q[X6/B
MGP\;> (+V%A) S' SW&?0C]0*N$N5D3C='G?A7X?>+=$\3Z??M;QQ113+YK"
M=3^[)PPP#SQFM)3BU8SC"2=ST7QG;W$EM;R1@M#&3O [$XP<?G71@I14FGN<
M&9PG*,6MD9?A""<ZOYJHPB5"';''L*Z,9*/L[=3DRV$_:\RV.I\0::^KZ)<6
M43A)) -I8\9!!Y_*O$JPYX.*/J\'76'K1J-:(X_P]X.U*PUF&]O3%##;G>3O
M!)XKEI4)1ES2Z'MXS,J-6BZ=.[;.JL?%.D:C??8[:YS*<[<J0&^A-=,:T).R
M9X]7 8BC#GG'0V:U.(9++'!$TLKJD:#+,QP *3=M6.,7)\L5J8">(M'U])]*
M@NF62XC9%+(5SD8XK'VL*GNIGHO!XC"M5I1T33.2@^'VJF^6.9X5MPW,H;.1
M[#K7*L-.^I[,LXH*%XWOV/3CG:0#@]J]$^4/++FRNX+MX9HG\T-SP3D^OO7T
M$9QE&Z>A\A.E4C-QDM3T718)[71[:&X_UJKR/3G@?E7BUY*51N.Q]/A82A1C
M&>Y?K$Z H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * .>\1Z_-I4D=O;(OF.NXLW.!TX%=F&PZJIRD>;C<7*@U&"
MU8[PWKDVJB6*X51)$ =R\;A]*,305*SB/ XN5>\9[HTM7LFU'2+JS1]CRQE5
M)Z ^_M7!./-%H]C#U51JQJ-;,\YT;PAK"ZY#YUN88[>57:1CP0#GY?6N"G0G
MSZK8^FQ.8X?V#Y7=M;?YE_QYJVHVNKQ6T%Q-;PB(,/+<KN.3SQ]*TQ,Y*5DS
MGRG#T9TG.23=^I>T-M0\2>"KVUGE+2EBD<LA/S8P>3]>,U=/FJTFF<^*5+!X
MR,XK3=I&/H7@[5X]<MY;J'R(;>579]P.<'.!CK6-.A-33?0[<7F5!T'&#NVK
M'IU>B?*G%ZMXIOH=2E@MMD<<+E>5R6P>]>I1PD'!.74\+$8^K&HXPT2.DT74
MCJNFI<,@1\E6 Z9'I7#7I>RGRGJ86O[>FILT*Q.D* "@#%U#5[^RO4@33U=9
M7VQ,90-Q_I753HTYQNY;;Z'!6Q%6G-14-]M2Q>:E-8V%O/-; 2R2*C1[_NY]
M^]1"DIR:3T-:M>5*FI26K:1)>7YM;ZRMA'N^TLPW9QMP*F%/FC*78JI6Y)PA
M;XBM?ZM=6^J1V%I9K/(T7F<R;>Y']*TIT8RASR=C*MB)PJJE"-W:^Y/)?7-M
MH\MY<VHCFC!/E!\C\ZA4XRJ*$7H:2JSA1=2<;-="E#KURK6KWNG^3;W.!'*L
MFX9/3([5K+#QU4)7:,(XN:Y74A92V=S0U748]*L6N'&2#A5SC<?2L:5-U9<J
M.G$5U0ASLM0RK-"DJ'*.H8?0UFTXNS-8R4DI+J85OXBN72*XFT_99O)Y?FK)
MG:<XY'UKKEAHJ\5+7L>?#&S:4I0]UNU[ES4=3N;6^@M+6T6>252P!?;C%9TZ
M491<I.UC>M7G":A"-V_,FCN[M--GN;NU6&6)681B0-D 9ZBH<(N:C%W3+52H
MJ;G.-FO,AO=7-GI5O>B$,9B@V[L8W#/6JA1YYN%]B*N(]G2C4MO;\0UC4;O3
M8C-%9K- JY=S)MP<XZ44:<:CLW9AB:]2BN:,;KU%.HW,.CS7MS:".2,;A&),
MY'&#FCV<744(L?MIQHNI.-FNER1]5A@TB+4)U*K(BL$7DY(S@4E2;J."*>(C
M&BJLNMOQ(++4K^:XB6YTQX8I@2CAMVWO\WI53I0BGRRNT9TJ]64DIPLG_6HE
MWJ]RE_-:V=E]H-NH:3Y]IYYX'>G"C%Q4IRM<53$351PIQO;<UE)9%)4J2,X/
M45S/0[%JA:!A0 4 % !0 4 % !0 4 % &-K>@)K!CD$QBE0;0<9!%=-#$.CI
M:Z.'%8-8BSO9H@LM.A\+Z?<WDLC3/@;L#'?@#\35SJ/$S4%H9TJ,<#3E4;N4
M[3QF)+M4N;98HF.-X;.WW-:3P5HWB]3&GF:E.TXV1UE>>>P5+W2[#4MOVRTC
MF*?=++R/QJ90C+=&U*O5H_PY-$UO;0VD"P6\2Q1)]U$& *:2BK(B<Y3ES2=V
M1W]Y'I]E+=2 E8QG [GH!6E.#G)11SUJJI0<WT.9M_&KM<J+BU582<95CE?\
M:[Y8))>Z]3RH9HW*THZ%K4?",=[>O<Q71B\QMS*4W<GTY%9T\8X1Y6MC6MER
MJ3<XRM<V].L(M,LDMH22J\ECU)]:Y:E1U)<S.^C1C1@H1+59FP4 % &3JT$L
MNH:6\<;,L<V7(&=H]ZZ*,DH33[''B(2E4IM+9C?$EM+=:?%%$CL?/4G8,D#G
MFGAI*$VWV%C82G32BNJ*<FC/9ZQILD4MW<H';>96WA./IQ6BK*5.2:2,'AG3
MK0<6WOOK8CUZUFDUZ&80WK0B *7M1\P.3QFJP\DJ35U>_4C%TY.NI6=K=/F7
MIEDN/"TT4<-SO\LJ%F&9#SWK*+4:Z;:^6QT23EA6DG>W7<S[;3)[>[TEK@7-
MS;^6"8WRPA? QQV _2MI58RC/ELG^:.>G0E"=-RNU;[F7=4M;K4=4ACCA0V]
MLNX^<"$=CQCWP*RI3C3@VWJ^QOB*<ZU5)+2/?9DNA1W5FDNGW,;8A.8Y!DH5
M/8$^E37<9M3CU+PBG33I36VSZ%'1]">2TA>\EN%5)"_V9N%R#P<?K6M:NE)J
M"7J<^&PC<$ZC>^W0=XAMY9-3M)5ANVB5&#-:CY@?K2P\DH-77S'C(2=6+2=K
M=-S0M%:ZT.6W6*YB;8T0^U??.1U/Y_I64WRU5*Z^1TTTYT'!)K=:[F1-]MU*
MRLM,_L^>!HF3S)9%^0!1C@]ZZ(\E.4JG,F<4O:5H0H\C5K7;VT-G7XI)]#N8
MHD9W8#"J,D_,*YL.U&JFSNQD7*A)16H:I%))X?GB1&:0Q8"@9)-%)I54WW#$
M1<L.XI:V*EU87$_ARQCB3$]NL<GEMQDJOW?K6D*D8UI-[.YC4HSEAX);JS^Y
M;%FTU:XN;B.)M*N8<_?=QA5_'O43HQBF^9,UIXB<Y*+@T9NNQ%KQGMK&\6\0
M#R[B <-QT/M6U!VC:4E;LSEQ<6YWA%\W1K]3H+3SOL</VC'G;!OQZXYKCG;F
M?+L>E3YN1<^Y-4EA0 4 % !0 4 % !0 4 % !0!4U*R&HZ=-:%]GF 8;&<$'
M(_E6E*?LYJ1C7I>VIN'<Y>T\&3B[4W<T1@4Y(0G+#T]J[YXV/+[JU/)IY9)3
M]]JP[QE>7,=U!;1R,D/E[_E.,G)'^?K2P4(N+D]QYG5G&2@G96%\'7UU)<36
MTCM)"$W@L<[3D#'^?2C&4XI*2W#+*LY2<'JC(UV^NY-8N5>5U$<A5%!P  >*
MZ:%."IJR.+%U:CK23>S.FTF-]:\+&"[D9BV4#GD\'@^_/\JX*S5&O>)ZV'3Q
M.%Y9LSK?P5,+E3/<QF ')"@Y(]/:MY8U6]U:G+#*Y*7O2T.RZ5YA[@4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % %2^TVUU*)8[J+>%.0<X(_&M*=25-WBS&K0A65IH6QT^UT
MV$Q6L6Q2<GDDD_4T5*DJCO)CI4845RP5B&]T33]0F$MS!ND QD,1GZXJH5ZE
M-6BS.KA:59\TUJ78HHX(ECB0(BC 4# %9-MN[.B,5%66P^D,* "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
$"@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g402146sp5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g402146sp5.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /?Z (H)UN(RZ!@ S+\PP<@D'^5 "SSQ6T+33.$C09+,>!0
ML,HG@25590X# ,,$?44 /H * "@ H * *ETNH&6,V<MNL8^^LJ$D_0@T 6Z
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MX#,6)8<?C0!;LM4%GH]G;VMG<W;QP(I94V)PHR2[8'\Z +^C:H^JVDMP]MY
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M86%L!QO.,[L>_0>WUH NRW<5ZUM:02!C*%FD [1]>?J<#\Z &V49;Q'J<_\
M"$BB'U )/_H0H UJ "@!"H/4 _6@"I_9=G_:'VWR1Y_KDXSZXZ9QQF@ _LJR
M%^;T0@3GJ<G!/3..F<<9ZT 6E140(J@*!@ = * (K:SM[,$01! ?3^7T]J )
M3&A=7*@NO ..10!'+;)-/!*W6$DJ/<C&?RS0!5GT:SN+[[7(C%_EW+O.QR.A
M*]"1F@"^  , 8% %>UL+2Q5A:V\<6XY;:,9H 98V[12W<KC!GF+X]@ H_P#0
=: +E !0 4 % !0 4 % !0 4 % !0 4 % !0!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
